https://curecurrent.com/trials/atypical-antipsychotic-treatment-effect-on-brain-function-in-schizophrenia-measured-by-fmri-124007https://curecurrent.com/trials/efficacy-safety-study-of-oral-aripiprazole-in-adolescents-with-schizophrenia-124008https://curecurrent.com/trials/amisulpride-augmentation-in-clozapine-unresponsive-schizophrenia-124009https://curecurrent.com/trials/open-label-extension-study-of-aripiprazole-intramuscular-depot-opc-14597-lu-af41155-in-patients-with-schizophrenia-124010https://curecurrent.com/trials/social-cognition-and-interaction-training-for-adults-with-psychotic-disorders-an-open-pilot-study-in-finland-124011https://curecurrent.com/trials/l-arginine-add-on-therapy-in-patients-with-schizophrenia-124012https://curecurrent.com/trials/evaluation-of-olanzapine-treatment-124013https://curecurrent.com/trials/how-reducing-anxiety-in-schizophrenia-124014https://curecurrent.com/trials/auditory-verbal-hallucinations-in-schizophrenia-124015https://curecurrent.com/trials/safety-and-tolerability-study-of-lu-af35700-after-repeated-dosing-in-patients-with-schizophrenia-124016https://curecurrent.com/trials/pharmacokinetic-properties-of-various-modified-release-tablet-formulations-of-lu-af11167-124017https://curecurrent.com/trials/pharmacologic-and-clinical-testing-of-a-d1-agonist-for-cognitive-enhancement-in-neuropsychiatric-disorders-124018https://curecurrent.com/trials/bioavailability-of-ly03004-and-risperdal-consta-124019https://curecurrent.com/trials/open-label-study-to-compare-hospitalization-rates-of-schizophrenic-patients-treated-with-oral-antipsychotics-versus-im-d-124020https://curecurrent.com/trials/metacognitive-training-in-schizophrenia-124021https://curecurrent.com/trials/pharmacokinetic-study-of-min-101-in-healthy-subjects-124022https://curecurrent.com/trials/rehabilitation-and-quality-of-life-in-residential-units-for-people-with-longer-term-mental-health-problems-124023https://curecurrent.com/trials/safety-and-tolerability-of-multiple-doses-of-iti-214-in-healthy-adults-and-in-adults-with-stable-schizophrenia-124024https://curecurrent.com/trials/safety-and-tolerability-study-of-lu-af11167-after-repeated-dosing-in-patients-with-schizophrenia-124025https://curecurrent.com/trials/rtms-induced-cumulative-pattern-of-sbdnf-in-chronic-schizophrenia-124026https://curecurrent.com/trials/prevention-of-relapse-with-injectable-paliperidone-palmitate-versus-oral-antipsychotics-124027https://curecurrent.com/trials/omega-3-fatty-acids-efficacy-in-first-episode-of-schizophrenia-124028https://curecurrent.com/trials/trial-of-aripiprazole-intramuscular-depot-opc-14597-lu-af41155-in-the-acute-treatment-of-adults-with-schizophrenia-124029https://curecurrent.com/trials/exploration-of-neural-bases-in-social-cognition-124030https://curecurrent.com/trials/clinical-estradiol-trial-in-women-with-schizophrenia-124031https://curecurrent.com/trials/evaluation-of-social-skills-intervention-on-cognitive-function-in-schizophrenia-124032https://curecurrent.com/trials/selective-estrogen-receptor-modulators-a-potential-treatment-for-psychotic-symptoms-of-schizophrenia-124033https://curecurrent.com/trials/efficacy-of-a-triptan-in-the-treatment-of-hostility-and-aggression-among-convicts-with-a-psychiatric-treatment-order-124034https://curecurrent.com/trials/effectiveness-and-safety-of-amisulpride-in-chinese-patients-with-schizophrenia-124035https://curecurrent.com/trials/effectiveness-of-meta-cognitive-training-emc-in-people-with-psychosis-of-brief-evolution-124036https://curecurrent.com/trials/bifeprunox-in-the-treatment-of-schizophrenia-124037https://curecurrent.com/trials/twice-daily-titration-study-of-bifeprunox-in-subjects-with-schizophrenia-124038https://curecurrent.com/trials/nicotine-effects-on-endophenotypes-of-schizophrenia-124039https://curecurrent.com/trials/to-evaluate-the-impact-of-treatment-interruption-on-re-initiation-of-bifeprunox-124040https://curecurrent.com/trials/progressively-decreasing-titration-schedules-of-bifeprunox-in-subjects-with-schizophrenia-or-bipolar-disorder-124041https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-pharmacokinetic-pk-and-pharmacodynamic-pd-effects-of-evp-6308-and-the-potential-124042https://curecurrent.com/trials/evaluation-of-a-statewide-program-to-prevent-early-mortality-and-to-promote-fitness-in-persons-with-smi-124043https://curecurrent.com/trials/valproate-in-late-life-schizophrenia-124044https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-paliperidone-palmitate-in-the-prevention-of-relapse-of-the-symptoms-of-schizoaffecti-124045https://curecurrent.com/trials/customized-adherence-enhancement-plus-long-acting-injectable-antipsychotic-124046https://curecurrent.com/trials/validation-of-the-french-warwick-edinburgh-mental-well-being-scale-wemwbs-124047https://curecurrent.com/trials/early-pharmacological-and-psychological-intervention-for-late-prodromal-states-of-psychosis-124048https://curecurrent.com/trials/a-follow-up-safety-study-of-patients-who-participated-in-previous-studies-of-the-drug-org-24448-study-p05719-completed-124049https://curecurrent.com/trials/aripiprazole-for-schizophrenia-outpatients-completing-bms-clinical-trials-124050https://curecurrent.com/trials/study-in-adolescents-with-schizophrenia-or-bipolar-disorder-124051https://curecurrent.com/trials/brief-motivational-enhancement-therapy-for-concurrent-disorders-124052https://curecurrent.com/trials/neuroplasticity-oriented-cognitive-intervention-in-early-onset-and-first-admission-schizophrenia-124053https://curecurrent.com/trials/prevalence-of-clinical-and-laboratory-markers-of-hypofibrinolysis-in-psychotic-patients-124054https://curecurrent.com/trials/yoga-and-aerobic-exercise-in-psychosis-124055https://curecurrent.com/trials/cognitive-remediation-in-schizophrenia-124056https://curecurrent.com/trials/metabolic-syndrome-in-patients-with-first-episode-schizophrenia-124057https://curecurrent.com/trials/intramuscular-depot-formulation-of-aripiprazole-as-maintenance-treatment-in-patients-with-schizophrenia-124058https://curecurrent.com/trials/an-open-trial-of-cysteamine-treatment-in-schizophrenia-124059https://curecurrent.com/trials/poc-study-of-pipamperone-added-to-stable-treatment-with-ris-or-pal-in-chronic-schizophrenia-124060https://curecurrent.com/trials/effectiveness-of-ziprasidone-for-patients-with-schizophrenia-124061https://curecurrent.com/trials/pharmacokinetic-and-safety-study-of-ly03004-in-stable-patients-with-schizophrenia-or-schizoaffective-disorder-124062https://curecurrent.com/trials/cerebral-reorganization-in-schizophrenia-124063https://curecurrent.com/trials/study-in-stabilized-schizophrenic-patients-to-evaluate-the-pharmacokinetics-of-risperidone-and-9-hydroxy-oh-risperidone-124064https://curecurrent.com/trials/treatment-study-for-cognitive-deficits-in-schizophrenia-124065https://curecurrent.com/trials/brief-culturally-adapted-cognitive-behavior-therapy-for-psychosis-124066https://curecurrent.com/trials/art-therapy-in-acute-schizophrenia-124067https://curecurrent.com/trials/cognitive-behavioral-therapy-for-patients-with-an-early-psychosis-124068https://curecurrent.com/trials/safety-and-tolerability-trial-of-aripiprazole-im-depot-treatment-in-adult-subjects-with-schizophrenia-stabilized-on-oral-124069https://curecurrent.com/trials/predictors-of-response-to-cognitive-remediation-in-schizophrenia-124070https://curecurrent.com/trials/20110165-study-to-evaluate-the-effect-of-amg-747-on-schizophrenia-negative-symptoms-study-165-124071https://curecurrent.com/trials/an-efficacy-study-of-paliperidone-for-the-prevention-of-relapse-in-participants-with-schizophrenia-124072https://curecurrent.com/trials/risperdal-consta-and-health-care-utilization-in-patients-with-schizophrenia-124073https://curecurrent.com/trials/theta-burst-transcranial-magnetic-stimulation-as-treatment-for-auditory-verbal-hallucinations-124074https://curecurrent.com/trials/determining-the-effects-of-risperdal-consta-in-patients-with-psychotic-disorders-and-incomplete-adherence-124075https://curecurrent.com/trials/mindfulness-rct-for-early-psychosis-124076https://curecurrent.com/trials/treatment-of-patients-with-recently-exacerbated-schizophrenia-with-paliperidone-palmitate-124077https://curecurrent.com/trials/phase-iib-iii-study-of-bl-1020-small-molecule-for-schizophrenia-124078https://curecurrent.com/trials/treatment-on-iatrogenic-weight-gain-and-dyslipidaemia-associated-with-olanzapine-124079https://curecurrent.com/trials/intramuscular-im-olanzapine-versus-im-haloperidol-plus-lorazepam-for-acute-agitation-in-schizophrenia-124080https://curecurrent.com/trials/effects-of-aripiprazole-and-haloperidol-on-mesolimbic-system-functioning-124081https://curecurrent.com/trials/trial-of-d-cycloserine-in-schizophrenia-124082https://curecurrent.com/trials/phase-4-study-to-evaluate-efficacy-of-paliperidone-extended-release-er-in-schizophrenic-participants-124083https://curecurrent.com/trials/effects-of-eszopiclone-on-sleep-dependent-learning-in-schizophrenia-124084https://curecurrent.com/trials/trial-of-nicotine-nasal-spray-as-an-aid-for-smoking-cessation-in-schizophrenia-124085https://curecurrent.com/trials/effects-of-cognitive-remediation-on-cognition-in-young-people-at-clinical-high-risk-of-psychosis-124086https://curecurrent.com/trials/how-can-rehospitalisations-of-patients-with-schizophrenia-be-avoided-a-comparison-between-different-compliance-programs-124087https://curecurrent.com/trials/effectiveness-of-family-group-interventions-for-people-with-schizophrenia-124088https://curecurrent.com/trials/efficacy-of-repetitive-transcranial-magnetic-stimulation-in-the-prevention-of-relapse-of-schizoaffective-124089https://curecurrent.com/trials/a-study-of-fk199b-to-compare-efficacy-with-zolpidem-by-polysomnography-in-patients-with-insomnia-124090https://curecurrent.com/trials/a-double-blind-group-comparison-p-iii-study-with-zolpidem-mr-using-placebo-and-nitrazepam-in-insomnia-patients-124091https://curecurrent.com/trials/effectiveness-of-vitamin-supplementation-in-treating-people-with-residual-symptoms-of-schizophrenia-124092https://curecurrent.com/trials/the-influence-of-aerobic-exercise-on-cognitive-functioning-in-schizophrenia-124093https://curecurrent.com/trials/clinical-symptoms-of-schizophrenia-and-physical-exercise-124094https://curecurrent.com/trials/effects-of-weekly-dosing-of-d-cycloserine-on-cognitive-function-in-individuals-with-schizophrenia-124095https://curecurrent.com/trials/a-comparative-study-to-evaluate-the-evolution-of-medication-satisfaction-and-adherence-in-patients-unsatisfied-with-curr-124096https://curecurrent.com/trials/cardio-risk-of-acute-schizophrenia-olanzapine-duke-124097https://curecurrent.com/trials/an-open-label-study-of-aripiprazole-intramuscular-injection-in-subjects-with-schizophrenia-124098https://curecurrent.com/trials/effects-of-a-cognitive-rehabilitation-program-a-neurocognitive-study-124099https://curecurrent.com/trials/metabolic-signatures-and-biomarkers-in-schizophrenia-124100https://curecurrent.com/trials/study-to-measure-the-safety-of-paliperidone-er-extended-release-in-patients-with-liver-disease-124101https://curecurrent.com/trials/varenicline-and-smoking-cessation-in-schizophrenia-124102https://curecurrent.com/trials/the-effectiveness-of-the-meta-cognitive-training-among-patients-with-chronic-schizophrenia-124103https://curecurrent.com/trials/decreased-eeg-complexity-in-schizophrenia-124104https://curecurrent.com/trials/treatment-of-n-methyl-d-aspartate-nmda-enhancers-for-schizophrenia-124105https://curecurrent.com/trials/web-based-support-for-people-with-schizophrenia-and-their-families-124106https://curecurrent.com/trials/treatment-of-schizophrenia-through-internet-based-psychoeducation-124107https://curecurrent.com/trials/bioequivalence-fasting-study-in-patients-124108https://curecurrent.com/trials/a-comparative-study-of-patient-satisfaction-between-continued-administration-of-previous-antipsychotics-versus-switched-124109https://curecurrent.com/trials/comparison-of-paliperidone-palmitate-and-risperdal-consta-in-patients-with-schizophrenia-124110https://curecurrent.com/trials/a-study-of-paliperidone-palmitate-in-japanese-patients-with-schizophrenia-124111https://curecurrent.com/trials/a-study-of-ro4917838-in-combination-with-antipsychotic-treatment-in-patients-with-schizophrenia-124112https://curecurrent.com/trials/effectiveness-of-aripiprazole-for-improving-side-effects-of-clozapine-in-the-treatment-of-people-with-schizophrenia-124113https://curecurrent.com/trials/a-study-of-the-efficacy-effectiveness-of-paliperidone-palmitate-in-the-prevention-of-recurrence-of-the-symptoms-of-schiz-124114https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-flexible-doses-of-extended-release-er-paliperidone-compared-with-flexible-124115https://curecurrent.com/trials/a-study-to-assess-learning-performance-in-patients-with-schizophrenia-and-young-and-elderly-healthy-volunteers-124116https://curecurrent.com/trials/medication-adherence-in-schizophrenia-development-of-a-cbt-based-intervention-124117https://curecurrent.com/trials/effect-of-motivational-therapy-on-schizophrenia-with-cannabis-misuse-124118https://curecurrent.com/trials/glycine-and-d-cycloserine-in-schizophrenia-124119https://curecurrent.com/trials/lurasidone-hcl-a-phase-3-study-of-patients-with-acute-schizophrenia-124120https://curecurrent.com/trials/effectiveness-of-cognitive-remediation-in-a-supported-education-setting-124121https://curecurrent.com/trials/enhancing-the-prospective-prediction-of-psychosis-124122https://curecurrent.com/trials/melatonin-versus-placebo-for-benzodiazepine-discontinuation-in-patients-with-schizophrenia-124123https://curecurrent.com/trials/aripiprazole-treatment-of-prodromal-patients-124124https://curecurrent.com/trials/effectiveness-of-atypical-versus-conventional-antipsychotics-in-treating-schizophrenia-124125https://curecurrent.com/trials/effectiveness-and-safety-of-3-fixed-doses-25-mg-eq-100-mg-eq-and-150-mg-eq-of-paliperidone-palmitate-in-patients-with-sc-124126https://curecurrent.com/trials/an-efficacy-and-safety-study-of-one-dosage-of-paliperidone-extended-release-er-in-treating-patients-with-schizophrenia-124127https://curecurrent.com/trials/sarcosine-preventive-therapy-for-individuals-at-high-risk-for-schizophrenia-124128https://curecurrent.com/trials/paliperidone-extended-release-er-effectiveness-study-to-evaluate-the-objective-symptom-change-and-symptomatic-remission-124129https://curecurrent.com/trials/investigation-of-the-safety-tolerability-and-potential-therapeutic-effects-of-jnj-40411813-in-patients-with-schizophreni-124130https://curecurrent.com/trials/a-safety-and-pharmacokinetic-study-of-paliperidone-palmitate-in-patients-with-schizophrenia-124131https://curecurrent.com/trials/efficacy-study-exploring-the-effects-on-cognition-of-sertindole-versus-comparator-in-patients-with-schizophrenia-124132https://curecurrent.com/trials/the-role-of-antidepressants-or-antipsychotics-in-preventing-psychosis-124133https://curecurrent.com/trials/once-daily-asenapine-for-schizophrenia-124134https://curecurrent.com/trials/medical-chart-review-of-patients-on-long-term-treatment-with-long-acting-injectable-risperidone-124135https://curecurrent.com/trials/ethyl-epa-treatment-of-prodromal-patients-124136https://curecurrent.com/trials/shiatsu-adjuvant-therapy-for-schizophrenia-124137https://curecurrent.com/trials/characterization-of-intramuscular-injections-of-risperidone-4-week-long-acting-injectable-lai-formulation-in-the-buttock-124138https://curecurrent.com/trials/the-efficacy-and-safety-of-quetiapine-xr-in-patients-with-schizophrenia-switched-from-other-antipsychotics-124139https://curecurrent.com/trials/antipsychotic-to-treat-psychosis-syndrome-124140https://curecurrent.com/trials/efficacy-and-safety-of-a-prexa-compared-to-zyprexa-in-patients-with-schizophrenia-124141https://curecurrent.com/trials/evaluation-of-effectiveness-and-safety-of-flexible-dose-paliperidone-extended-release-in-patients-with-schizoaffective-d-124142https://curecurrent.com/trials/study-to-measure-drug-satisfaction-of-patients-with-schizophrenia-after-switching-from-risperidone-to-paliperidone-124143https://curecurrent.com/trials/an-observational-study-to-evaluate-efficacy-and-safety-of-risperidone-long-acting-injection-for-treatment-of-schizophren-124144https://curecurrent.com/trials/a-6-month-study-to-compare-the-metabolic-effects-of-paliperidone-er-and-olanzapine-in-patients-with-schizophrenia-124145https://curecurrent.com/trials/a-follow-up-study-of-schizophrenic-participants-following-treatment-discontinuation-after-remission-from-a-first-psychot-124146https://curecurrent.com/trials/intensive-transcranial-magnetic-stimulation-for-negative-symptoms-in-schizophrenia-124147https://curecurrent.com/trials/safety-efficacy-and-tolerability-study-of-paliperidone-extended-release-er-in-participants-with-schizophrenia-124148https://curecurrent.com/trials/does-acute-oxytocin-administration-enhance-social-cognition-in-individuals-with-schizophrenia-124149https://curecurrent.com/trials/switching-from-oral-antipsychotics-to-long-acting-risperidone-in-participants-with-schizophrenia-124150https://curecurrent.com/trials/a-study-to-evaluate-effectiveness-and-safety-of-er-oros-paliperidone-in-patients-with-schizophrenia-124151https://curecurrent.com/trials/effects-of-pravastatin-on-cholesterol-inflammation-and-cognition-in-schizophrenia-124152https://curecurrent.com/trials/invision-an-observational-study-to-explore-effectiveness-tolerability-and-safety-of-paliperidone-er-in-patients-with-sch-124153https://curecurrent.com/trials/safety-and-cognitive-function-study-of-evp-6124-in-patients-with-schizophrenia-124154https://curecurrent.com/trials/measuring-the-effect-of-remote-monitoring-of-treatment-adherence-on-the-risk-of-re-admission-of-ambulatory-schizophrenic-124155https://curecurrent.com/trials/safety-and-tolerability-study-of-drug-to-treat-schizophrenia-124156https://curecurrent.com/trials/a-comparison-of-study-drug-with-placebo-and-haloperidol-in-patients-with-schizophrenia-124157https://curecurrent.com/trials/a-study-to-test-the-safety-and-tolerability-of-a-new-medication-in-the-treatment-of-schizophrenia-124158https://curecurrent.com/trials/a-4-week-randomized-rater-blinded-parallel-study-to-evaluate-quetiapine-in-improving-sleep-quality-of-schizophrenia-124159https://curecurrent.com/trials/a-study-of-relapse-prevention-and-the-effectiveness-of-long-acting-injectable-risperidone-and-quetiapine-tablets-in-the-124160https://curecurrent.com/trials/an-efficacy-and-safety-study-of-long-term-risperidone-microspheres-in-participants-with-schizophrenia-124161https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-of-the-safety-and-efficacy-of-paliperidone-extended-release-er-in-the-treatment-124162https://curecurrent.com/trials/pragmatic-rct-comparing-aripiprazole-olanzapine-and-haloperidol-in-the-treatment-of-schizophrenia-124163https://curecurrent.com/trials/comparison-of-the-effects-of-aripiprazole-and-risperidone-on-the-pattern-of-brain-activation-in-schizophrenic-patients-124164https://curecurrent.com/trials/schizophrenia-treatment-adherence-investigation-stai-124165https://curecurrent.com/trials/ketamine-challenge-study-with-jnj-40411813-124166https://curecurrent.com/trials/a-drug-interaction-study-of-valproic-acid-and-paliperidone-extended-release-er-in-patients-with-schizophrenia-bipolar-i-124167https://curecurrent.com/trials/observational-study-in-patients-with-schizophrenia-treated-with-long-acting-risperidone-injection-risperdal-consta-124168https://curecurrent.com/trials/a-study-to-evaluate-treatment-adherence-in-schizophrenia-with-long-acting-risperidone-microspheres-e-star-124169https://curecurrent.com/trials/molecular-genetics-of-schizophrenia-124170https://curecurrent.com/trials/a-study-to-observe-safety-and-blood-concentrations-of-pf-06412562-during-and-following-the-oral-administration-of-multip-124171https://curecurrent.com/trials/efficacy-study-of-paliperidone-to-evaluate-subjective-change-in-well-being-and-drug-attitude-in-schizophrenic-participan-124172https://curecurrent.com/trials/treatment-of-early-onset-schizophrenia-spectrum-disorders-teoss-124173https://curecurrent.com/trials/an-efficacy-and-safety-study-of-3-fixed-doses-of-jnj-37822681-in-participants-with-schizophrenia-124174https://curecurrent.com/trials/association-of-amisulpride-response-in-schizophrenia-with-brain-image-124175https://curecurrent.com/trials/routine-outcome-monitoring-in-mental-health-outpatient-124176https://curecurrent.com/trials/the-mechanism-of-tcf7l2-and-slc30a8-on-antipsychotic-induced-metabolic-syndrome-124177https://curecurrent.com/trials/study-evaluating-vabicaserin-in-subjects-with-schizophrenia-124178https://curecurrent.com/trials/scale-validation-study-for-prediction-of-relapse-and-short-term-rehospitalization-in-patients-with-schizophrenia-124179https://curecurrent.com/trials/a-pharmacokinetics-study-to-evaluate-safety-and-tolerability-of-jnj-37822681-in-participants-with-stable-schizophrenia-124180https://curecurrent.com/trials/health-promotion-and-fitness-for-younger-and-older-adults-with-smi-124181https://curecurrent.com/trials/effects-of-cdp-choline-on-gating-and-cognitive-deficits-in-first-episode-schizophrenia-124182https://curecurrent.com/trials/effects-of-antipsychotic-medications-on-energy-intake-and-expenditure-124183https://curecurrent.com/trials/an-efficacy-and-safety-study-of-long-acting-injectable-risperidone-and-oral-risperidone-in-participants-with-schizophren-124184https://curecurrent.com/trials/effectiveness-of-targeted-cognitive-training-for-neurological-deficits-in-people-with-schizophrenia-124185https://curecurrent.com/trials/paliperidone-palmitate-flexible-dosing-in-schizophrenia-124186https://curecurrent.com/trials/paliperidone-extended-release-er-dosing-and-clinical-response-in-acute-schizophrenia-124187https://curecurrent.com/trials/early-prediction-of-clinical-response-in-patients-with-schizophrenia-treated-by-paliperidone-er-124188https://curecurrent.com/trials/indicated-prevention-with-long-chain-polyunsaturated-omega-3-fatty-acids-in-patients-with-22q11-microdeletion-syndrome-124189https://curecurrent.com/trials/cognitive-remediation-therapy-and-schizophrenia-124190https://curecurrent.com/trials/study-of-aripiprazole-in-patients-with-schizophrenia-effects-on-glucose-metabolism-124191https://curecurrent.com/trials/research-and-evaluation-of-antipsychotic-treatment-in-community-behavioral-health-organizations-124192https://curecurrent.com/trials/a-positron-emission-tomography-pet-study-to-measure-the-blockade-of-dopamine-receptors-d2-in-specific-areas-of-the-brain-124193https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-flexibly-dosed-paliperidone-extended-release-er-in-participants-with-schizo-124194https://curecurrent.com/trials/prevalence-of-dissociative-disorders-in-children-124195https://curecurrent.com/trials/open-label-observational-pilot-study-to-evaluate-the-pharmacokinetics-of-aripiprazole-in-subjects-with-bipolar-1-disorde-124196https://curecurrent.com/trials/electroconvulsive-therapy-ect-in-patients-with-super-refractory-schizophrenia-124197https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-iloperidone-depot-in-schizophrenic-patients-124198https://curecurrent.com/trials/a-multiple-dose-safety-tolerability-and-pharmacokinetics-study-in-adult-patients-with-schizophrenia-following-administra-124199https://curecurrent.com/trials/tandospirone-combined-with-atypical-antipsychotic-drugs-in-schizophrenia-124200https://curecurrent.com/trials/symptomatic-remission-and-social-function-in-participants-treated-with-paliperidone-extended-release-er-124201https://curecurrent.com/trials/a-study-to-evaluate-flexible-dose-of-paliperidone-extended-release-er-and-clinical-response-in-participants-with-schizop-124202https://curecurrent.com/trials/risk-factors-for-postpartum-psychosis-124203https://curecurrent.com/trials/body-mass-index-bmi-and-metabolic-changes-following-switch-to-aripiprazole-from-olanzapine-risperidone-and-quetiapine-124204https://curecurrent.com/trials/investigator-initiated-study-asenapine-early-psychosis-124205https://curecurrent.com/trials/determining-the-safety-and-effectiveness-of-olanzapine-in-children-and-adolescents-124206https://curecurrent.com/trials/duration-of-untreated-psychosis-dup-and-pathways-to-care-in-nordland-124207https://curecurrent.com/trials/treatment-with-ziprasidone-for-schizophrenia-patients-with-obsessive-compulsive-disorder-ocd-124208https://curecurrent.com/trials/network-dysfunction-schizophrenia-and-pharmacological-magnetic-resonance-imaging-phmri-124209https://curecurrent.com/trials/zyprexa-and-task-engagement-in-schizophrenia-124210https://curecurrent.com/trials/will-decreased-noradrenergic-activity-normalize-information-processing-in-patients-with-schizophrenia-124211https://curecurrent.com/trials/long-acting-injectable-risperidone-in-the-treatment-of-schizophrenia-124212https://curecurrent.com/trials/adjunctive-aripiprazole-in-the-treatment-of-risperidone-induced-hyperprolactinemia-124213https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-as-therapeutical-strategy-for-negative-symptoms-in-schizophrenia-124214https://curecurrent.com/trials/a-phase-4-study-to-assess-the-effects-of-aripiprazole-versus-other-atypical-antipsychotics-in-the-treatment-of-schizophr-124215https://curecurrent.com/trials/a-trial-comparing-risperidone-long-acting-injection-with-oral-antipsychotic-in-the-treatment-of-early-psychosis-124216https://curecurrent.com/trials/d-serine-monotherapy-for-schizophrenia-124217https://curecurrent.com/trials/a-novel-person-centered-treatment-component-for-substance-use-treatment-124218https://curecurrent.com/trials/the-effects-of-aripiprazole-on-the-processing-of-rewards-in-schizophrenia-124219https://curecurrent.com/trials/a-study-of-risperidone-long-acting-injection-versus-oral-antipsychotics-in-schizophrenia-participants-with-a-history-of-124220https://curecurrent.com/trials/pregnenolone-and-l-theanine-augmentation-in-the-treatment-for-schizophrenia-and-schizoaffective-disorders-124221https://curecurrent.com/trials/trial-comparing-the-effects-of-aripiprazole-with-those-of-standard-of-care-on-non-hdl-cholesterol-in-patients-with-schiz-124222https://curecurrent.com/trials/a-pilot-study-of-boredom-in-a-community-sample-of-adolescents-and-a-clinical-sample-of-adolescents-124223https://curecurrent.com/trials/administrating-oxytocin-to-treat-treatment-schizophrenia-and-schizo-affective-patients-124224https://curecurrent.com/trials/f-18-altanserin-pet-study-of-patients-receiving-clozapine-124225https://curecurrent.com/trials/a-study-to-evaluate-participants-satisfaction-quality-of-life-and-effectiveness-of-flexible-dose-of-paliperidone-extende-124226https://curecurrent.com/trials/once-weekly-d-cycloserine-for-schizophrenia-124227https://curecurrent.com/trials/efficacy-and-safety-study-of-iloperidone-virus-risperidone-to-treat-schizophrenia-124228https://curecurrent.com/trials/study-of-alternate-formulation-of-aripiprazole-in-agitated-patients-with-schizophrenic-disorders-124229https://curecurrent.com/trials/effects-of-aripiprazole-in-overweight-patients-treated-with-olanzapine-for-schizophrenia-or-schizoaffective-disorder-124230https://curecurrent.com/trials/study-of-three-doses-of-aripiprazole-in-patients-with-acute-schizophrenia-124231https://curecurrent.com/trials/broad-effectiveness-study-with-aripiprazole-124232https://curecurrent.com/trials/effect-on-cognitive-function-of-a-treatment-with-aripiprazole-124233https://curecurrent.com/trials/a-study-of-aripiprazole-in-the-management-of-patients-with-schizophrenia-in-the-general-psychiatric-practices-124234https://curecurrent.com/trials/aripiprazole-used-as-dual-therapy-in-the-treatement-of-patients-with-chronic-stable-schizophrenia-or-schizoaffective-dis-124235https://curecurrent.com/trials/comparative-study-of-aripiprazole-and-olanzapine-in-the-treatment-of-patients-with-acute-schizophrenia-124236https://curecurrent.com/trials/a-d2-receptor-occupancy-and-fmri-study-in-schizophrenic-subjects-treated-with-lurasidone-124237https://curecurrent.com/trials/treatment-response-to-rehabilitation-in-patients-with-schizophrenia-124238https://curecurrent.com/trials/a-study-of-adjunctive-treatment-of-aripiprazole-in-schizophrenic-patients-124239https://curecurrent.com/trials/schizophrenia-trial-of-aripiprazole-124240https://curecurrent.com/trials/aripiprazole-oral-acceptability-trial-124241https://curecurrent.com/trials/a-study-of-aripiprazole-in-patients-with-schizophrenia-in-general-psychiatric-practices-124242https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-for-the-treatment-of-negative-symptoms-in-schizophrenia-124243https://curecurrent.com/trials/risperidone-augmentation-in-patients-with-schizophrenia-124244https://curecurrent.com/trials/glyt-1-inhibitor-treatment-for-refractory-schizophrenia-124245https://curecurrent.com/trials/augmenting-zyprexa-with-naltrexone-to-ameliorate-metabolic-side-effects-124246https://curecurrent.com/trials/efficacy-and-safety-of-aripiprazole-in-patients-with-schizophrenia-or-bipolar-disorder-124247https://curecurrent.com/trials/a-phase-4-study-to-evaluate-response-to-treatment-and-safety-of-paliperidone-extended-release-in-participants-with-schiz-124248https://curecurrent.com/trials/oral-aripiprazole-open-label-rollover-study-124249https://curecurrent.com/trials/enhancing-the-outcome-of-skills-training-for-people-with-schizophrenia-124250https://curecurrent.com/trials/study-on-metabolic-parameters-of-sertindole-in-patients-with-schizophrenia-124251https://curecurrent.com/trials/sertindole-in-asian-patients-with-schizophrenia-124252https://curecurrent.com/trials/bifeprunox-extension-to-extension-study-in-patients-with-schizophrenia-124253https://curecurrent.com/trials/exploratory-cognition-study-of-sertindole-in-patients-with-schizophrenia-124254https://curecurrent.com/trials/a-clinical-pharmacology-study-of-jns010-paliperidone-palmitate-in-patients-with-schizophrenia-124255https://curecurrent.com/trials/tc-5619-as-augmentation-therapy-to-improve-cognition-in-outpatients-with-cognitive-dysfunction-in-schizophrenia-124256https://curecurrent.com/trials/patient-reported-outcomes-in-the-treatment-of-schizophrenia-124257https://curecurrent.com/trials/epigenetic-regulation-of-bdnf-in-schizophrenia-124258https://curecurrent.com/trials/serum-clozapine-and-cognition-124259https://curecurrent.com/trials/therapeutic-effect-of-quetiapine-on-methamphetamine-induced-psychosis-124260https://curecurrent.com/trials/mitochondria-and-schizophrenia-effects-of-antipsychotic-drugs-124261https://curecurrent.com/trials/treatment-of-post-traumatic-stress-disorder-in-patients-with-other-mental-illnesses-124262https://curecurrent.com/trials/relapse-prevention-in-first-episode-schizophrenia-a-5-year-trial-124263https://curecurrent.com/trials/comparing-the-effects-of-sertindole-and-olanzapine-on-cognition-serola-124264https://curecurrent.com/trials/efficacy-of-repyflec-cognitive-remediation-group-training-in-schizophrenia-124265https://curecurrent.com/trials/single-nucleotide-polymorphism-snp-in-schizophrenia-and-schizophrenia-spectrum-disorders-a-population-association-analys-124266https://curecurrent.com/trials/evaluating-the-cost-effectiveness-of-istdp-a-quasi-experimental-study-124267https://curecurrent.com/trials/an-efficacy-and-safety-study-of-risperidone-long-acting-microspheres-in-participants-with-schizophrenia-schizophreniform-124268https://curecurrent.com/trials/effects-of-acute-nicotine-treatment-on-neuroplasticity-and-memory-in-patients-with-schizophrenia-124269https://curecurrent.com/trials/effectiveness-of-a-lifestyle-intervention-for-increasing-physical-activity-in-adults-with-schizophrenia-124270https://curecurrent.com/trials/antidepressant-treatment-in-older-adults-with-schizophrenia-124271https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-voices-124272https://curecurrent.com/trials/a-study-of-flexibly-dosed-paliperidone-extended-release-tablets-in-participants-with-schizophrenia-124273https://curecurrent.com/trials/transcranial-magnetic-stimulation-tms-treatment-for-patients-with-persistent-auditory-hallucinations-124274https://curecurrent.com/trials/an-efficacy-and-safety-study-of-paliperidone-extended-release-er-tablets-in-participants-with-schizophrenia-124275https://curecurrent.com/trials/interventions-to-improve-functional-outcome-and-persistent-symptoms-in-schizophrenia-124276https://curecurrent.com/trials/improving-work-outcome-in-people-with-recent-onset-schizophrenia-124277https://curecurrent.com/trials/evaluation-of-effectiveness-and-safety-of-paliperidone-extended-release-in-patients-with-schizoaffective-disorder-124278https://curecurrent.com/trials/pyridoxal-kinase-activity-in-tardive-dyskinesia-124279https://curecurrent.com/trials/prevention-trial-of-family-focused-treatment-in-youth-at-risk-for-psychosis-124280https://curecurrent.com/trials/bexarotene-treatment-in-schizophrenia-124281https://curecurrent.com/trials/clozapine-im-and-aggression-in-schizophrenic-patients-124282https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-for-treatment-of-negative-syndrome-in-patients-with-schizophrenia-124283https://curecurrent.com/trials/social-dysfunction-and-brain-dysfunction-in-patients-with-schizophrenia-124284https://curecurrent.com/trials/intramuscular-depot-formulation-of-aripiprazole-as-maintenance-treatment-in-patients-with-schizophrenia-124285https://curecurrent.com/trials/long-acting-injectable-risperidone-in-patients-with-schizophrenia-after-an-acute-episode-124286https://curecurrent.com/trials/efficacy-and-safety-of-armodafinil-as-adjunctive-therapy-in-schizophrenic-adults-with-cognitive-deficits-124287https://curecurrent.com/trials/a-rct-study-in-schizophrenia-relapse-prevention-124288https://curecurrent.com/trials/a-comparative-study-of-paliperidone-palmitate-and-risperidone-long-acting-injection-lai-in-participants-with-schizophren-124289https://curecurrent.com/trials/twelve-month-study-comparing-paliperidone-palmitate-and-select-oral-antipsychotics-in-adults-with-schizophrenia-who-have-124290https://curecurrent.com/trials/the-genetic-basis-of-inherited-neurologic-deficits-in-people-with-schizophrenia-124291https://curecurrent.com/trials/treating-drug-resistant-childhood-schizophrenia-124292https://curecurrent.com/trials/compensatory-strategies-applied-to-cognitive-impairment-in-schizophrenia-124293https://curecurrent.com/trials/maintenance-of-efficacy-with-risperidone-long-acting-injectable-r-lai-in-patients-with-schizophrenia-or-schizoaffective-124294https://curecurrent.com/trials/inors-international-observational-registry-on-schizophrenia-with-injectable-risperidone-and-oral-antipsychotics-124295https://curecurrent.com/trials/an-efficacy-and-safety-study-of-extended-release-er-paliperidone-in-adolescent-participants-with-schizophrenia-124296https://curecurrent.com/trials/observe-real-life-allocation-of-atypical-antipsychotics-in-the-acute-inpatient-management-of-schizophrenia-124297https://curecurrent.com/trials/comparison-of-video-consent-versus-routine-consent-for-participation-in-research-studies-124298https://curecurrent.com/trials/occupational-therapy-in-the-rehabilitation-of-executive-functions-in-patients-with-schizophrenia-124299https://curecurrent.com/trials/an-efficacy-and-safety-study-of-paliperidone-palmitate-in-participants-with-schizophrenia-124300https://curecurrent.com/trials/the-effects-of-atomoxetine-on-cognition-and-brain-function-based-on-catechol-o-methyltransferase-comt-genotype-124301https://curecurrent.com/trials/rehabilitative-training-for-older-people-with-schizophrenia-124302https://curecurrent.com/trials/open-label-study-of-curcumin-c-3-complex-in-schizophrenia-124303https://curecurrent.com/trials/the-effect-of-repetitive-transcranial-magnetic-stimulation-rtms-on-working-memory-124304https://curecurrent.com/trials/study-of-amantadine-for-risperidone-consta-or-paliperidone-treated-patients-to-decrease-prolactin-elevation-124305https://curecurrent.com/trials/movement-disorders-caused-by-antipsychotic-drugs-in-older-patients-124306https://curecurrent.com/trials/a-pharmacokinetic-and-safety-study-of-paliperidone-palmitate-jns010-in-participants-with-schizophrenia-124307https://curecurrent.com/trials/paliperidone-extended-release-in-schizophrenia-participants-with-duration-of-illness-less-than-10-years-124308https://curecurrent.com/trials/indicated-prevention-of-psychotic-disorders-with-low-dose-lithium-124309https://curecurrent.com/trials/geriatric-psychiatry-and-pharmacovigilance-124310https://curecurrent.com/trials/measuring-smoking-behavior-in-people-with-schizophrenia-and-bipolar-disorder-124311https://curecurrent.com/trials/effectiveness-of-the-screen-test-immunize-reduce-risk-and-refer-stirr-intervention-for-people-with-both-a-mental-and-sub-124312https://curecurrent.com/trials/medication-adherence-in-older-people-with-psychosis-124313https://curecurrent.com/trials/effect-of-fluvoxamine-on-cognition-behavior-symptoms-and-mrna-and-protein-expression-in-schizophrenia-patients-124314https://curecurrent.com/trials/a-study-evaluating-lurasidone-for-the-treatment-of-schizophrenia-or-schizoaffective-disorder-in-subjects-switched-from-o-124315https://curecurrent.com/trials/treating-thought-problems-in-patients-with-schizophrenia-124316https://curecurrent.com/trials/study-comparing-patients-taking-olanzapine-and-patients-taking-aripiprazole-on-learning-of-vocational-skills-124317https://curecurrent.com/trials/study-with-information-technology-it-aided-preventive-program-in-schizophrenia-124318https://curecurrent.com/trials/social-cognition-and-interaction-training-for-improving-social-functioning-in-people-with-schizophrenia-124319https://curecurrent.com/trials/phase-iia-study-in-patients-with-schizophrenia-124320https://curecurrent.com/trials/graduated-recovery-intervention-program-for-enhancing-treatment-for-first-episode-psychosis-124321https://curecurrent.com/trials/pharmacological-approach-to-improve-the-outcome-of-social-cognition-training-124322https://curecurrent.com/trials/the-use-of-metformin-in-the-treatment-of-antipsychotic-induced-weight-gain-in-schizophrenia-the-mets-study-124323https://curecurrent.com/trials/efficacy-and-safety-study-of-clozapine-augmented-by-atomoxetine-versus-clozapine-augmented-by-placebo-in-patients-with-c-124324https://curecurrent.com/trials/a-pilot-study-of-the-use-of-risperidone-long-acting-injectable-in-the-treatment-of-patients-with-recent-onset-psychosis-124325https://curecurrent.com/trials/tolerability-safety-and-efficacy-of-flexibly-dosed-paliperidone-er-in-patients-with-schizophrenia-124326https://curecurrent.com/trials/switching-to-iloperidone-from-other-antipsychotics-in-schizophrenia-124327https://curecurrent.com/trials/appetite-increase-in-schizophrenia-patients-treated-with-atypical-antipsychotics-124328https://curecurrent.com/trials/a-multicenter-study-to-evaluate-the-effects-of-switching-to-aripiprazole-12-weeks-on-the-sexual-dysfunction-from-risperi-124329https://curecurrent.com/trials/metabolic-effects-of-melatonin-in-patients-treated-with-second-generation-antipsychotics-124330https://curecurrent.com/trials/fys-study-epidemiological-multicentre-cross-sectional-study-in-a-clinical-practice-environment-about-the-relationship-be-124331https://curecurrent.com/trials/safety-and-efficacy-study-of-paliperidone-extended-release-er-among-thai-schizophrenia-participants-124332https://curecurrent.com/trials/huperzine-for-cognitive-and-functional-impairment-in-schizophrenia-124333https://curecurrent.com/trials/add-on-therapy-to-risperidonein-schizophrenia-124334https://curecurrent.com/trials/relative-effectiveness-of-schizophrenia-therapy-study-124335https://curecurrent.com/trials/the-antiatherogenic-properties-of-hdl-in-psychiatric-patients-with-and-without-antipsychotic-therapy-124336https://curecurrent.com/trials/coaching-intervention-for-patients-with-early-psychosis-124337https://curecurrent.com/trials/effect-of-single-dose-intranasal-insulin-on-cognitive-function-124338https://curecurrent.com/trials/effect-of-talnetant-versus-risperidone-versus-placebo-on-psychotic-symptoms-in-schizophrenic-patients-124339https://curecurrent.com/trials/economic-and-clinical-outcomes-of-attendance-in-psychosis-services-using-sms-124340https://curecurrent.com/trials/self-regulation-strategies-to-improve-exercise-behavior-among-schizophrenic-patients-124341https://curecurrent.com/trials/study-evaluating-bifeprunox-in-patients-with-schizophrenia-124342https://curecurrent.com/trials/study-comparing-bifeprunox-to-risperidone-in-treatment-of-outpatients-with-schizophrenia-with-weight-as-primary-endpoint-124343https://curecurrent.com/trials/comparison-of-optimal-antipsychotic-treatments-for-adults-with-schizophrenia-124344https://curecurrent.com/trials/observational-study-to-assess-outcomes-during-antipsychotic-treatment-with-paliperidone-er-or-other-oral-antipsychotics-124345https://curecurrent.com/trials/study-evaluating-safety-and-tolerability-of-vabicaserin-in-patients-with-sudden-worsening-of-schizophrenia-124346https://curecurrent.com/trials/metformin-for-treatment-of-antipsychotic-induced-dyslipidemia-124347https://curecurrent.com/trials/oculomotor-and-spatial-cognition-deficits-in-schizophrenia-124348https://curecurrent.com/trials/adherence-and-quality-of-life-in-people-with-schizophrenia-and-schizoaffective-disorder-124349https://curecurrent.com/trials/l-carnosine-for-schizophrenia-124350https://curecurrent.com/trials/intensive-computerized-brain-training-icbt-in-youth-with-early-onset-psychosis-eop-124351https://curecurrent.com/trials/a-study-of-the-cataractogenic-potential-of-seroquel-and-risperdal-in-the-treatment-of-participants-with-schizophrenia-or-124352https://curecurrent.com/trials/naltrexone-treatment-of-alcohol-abuse-in-schizophrenia-124353https://curecurrent.com/trials/efficacy-and-safety-of-seroquel-extended-release-xr-in-acute-schizophrenia-124354https://curecurrent.com/trials/quetiapine-fumarate-seroquel-in-the-treatment-of-adolescent-patients-with-schizophrenia-and-bipolar-i-disorder-124355https://curecurrent.com/trials/a-large-pragmatic-cluster-randomized-controlled-trial-of-a-multi-element-psychosocial-intervention-for-early-psychosis-124356https://curecurrent.com/trials/sr-registration-study-1-row-efficacy-and-safety-of-seroquel-in-the-treatment-of-patients-with-schizophrenia-124357https://curecurrent.com/trials/seroquel-switching-study-feasibility-of-switching-any-antipsychotic-treatment-to-seroquel-in-patients-with-schizophrenia-124358https://curecurrent.com/trials/immediate-release-ir-to-sustained-release-sr-switching-study-study-of-switching-from-ir-seroquel-to-sr-seroquel-in-outpa-124359https://curecurrent.com/trials/a-comparison-of-seroquel-vs-risperidone-in-schizophrenia-124360https://curecurrent.com/trials/quetiapine-fumarate-seroquel-compared-to-placebo-in-the-treatment-of-adolescent-patients-with-schizophrenia-124361https://curecurrent.com/trials/relapse-prevention-row-study-to-evaluate-prevention-of-relapse-in-patients-in-stable-chronic-schizophrenia-receiving-eit-124362https://curecurrent.com/trials/seroquel-on-glucose-metabolism-124363https://curecurrent.com/trials/cafe-comparison-of-atypicals-in-first-episode-of-psychosis-124364https://curecurrent.com/trials/a-usability-study-of-a-smoking-cessation-decision-aid-in-people-with-a-recent-first-episode-of-psychosis-124365https://curecurrent.com/trials/the-evaluation-of-therapeutic-efficacy-on-the-integrated-group-psychotherapy-for-patients-with-schizophrenia-124366https://curecurrent.com/trials/a-drug-interaction-study-of-valproic-acid-and-single-dose-paliperidone-extended-release-er-in-healthy-men-124367https://curecurrent.com/trials/atypical-antipsychotics-in-the-treatment-of-affective-symptoms-of-schizophrenia-in-hungary-124368https://curecurrent.com/trials/intranasal-insulin-treatment-in-patients-with-schizophrenia-124369https://curecurrent.com/trials/recovery-from-psychosis-in-schizophrenia-the-impact-of-cognitive-behavioral-therapy-124370https://curecurrent.com/trials/a-study-of-treatment-success-in-changing-from-olanzapine-to-long-acting-injectable-risperidone-risperdal-consta-124371https://curecurrent.com/trials/an-open-label-multicentre-study-to-determine-the-dose-distribution-of-paliperidone-er-in-patients-with-schizophrenia-124372https://curecurrent.com/trials/rtms-effects-on-smoking-cessation-and-cognition-in-schizophrenia-124373https://curecurrent.com/trials/non-interventional-study-real-life-use-of-atypical-antipsychotics-in-acute-inpatient-management-of-schizophrenia-124374https://curecurrent.com/trials/olanzapine-given-in-combination-with-zonisamide-sr-to-prevent-weight-gain-in-schizophrenic-subjects-124375https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-the-effects-of-risperidone-compared-with-other-atypical-antipsychotic-drugs-on-the-gr-124376https://curecurrent.com/trials/a-study-to-compare-two-different-brain-imaging-techniques-in-healthy-volunteers-and-in-schizophrenic-patients-124377https://curecurrent.com/trials/a-study-to-observe-real-life-allocation-of-antipsychotics-in-acute-inpatient-management-of-schizophrenia-124378https://curecurrent.com/trials/n-methyl-d-aspartic-acid-nmda-and-cognitive-remediation-in-schizophrenia-124379https://curecurrent.com/trials/adjunctive-supplementation-of-antioxidants-vitamins-e-c-plus-omega-3-fatty-acids-124380https://curecurrent.com/trials/different-safety-profile-of-risperidone-and-paliperidone-extended-release-124381https://curecurrent.com/trials/a-trial-to-explore-the-tolerability-safety-and-efficacy-of-paliperidone-extended-release-in-patients-with-schizophrenia-124382https://curecurrent.com/trials/first-in-human-study-to-evaluate-amg-579-in-healthy-subjects-and-patients-with-stable-schizophrenia-124383https://curecurrent.com/trials/comparison-of-the-subjective-well-being-and-tolerability-of-quetiapine-xr-to-risperidone-124384https://curecurrent.com/trials/attention-shaping-procedures-for-improving-psychosocial-skills-among-adults-with-schizophrenia-124385https://curecurrent.com/trials/a-long-term-study-of-jns007er-in-patients-with-schizophrenia-124386https://curecurrent.com/trials/decision-aid-to-facilitate-shared-decision-making-during-treatment-in-schizophrenia-124387https://curecurrent.com/trials/a-positron-emission-tomography-study-of-slv354-in-healthy-subjects-and-subjects-with-schizophrenia-124388https://curecurrent.com/trials/a-study-of-the-effects-of-sarcosine-on-symptoms-and-brain-glycine-levels-in-people-with-schizophrenia-124389https://curecurrent.com/trials/the-consta-club-a-demonstration-project-for-setting-up-a-consta-club-in-a-community-mental-health-center-124390https://curecurrent.com/trials/the-effect-of-sertindole-on-sensory-gating-and-cognition-in-schizophrenic-patients-124391https://curecurrent.com/trials/ibis-italian-burden-of-illness-on-schizophrenia-bipolar-disorder-124392https://curecurrent.com/trials/transcutaneous-non-invasive-vagus-nerve-stimulation-t-vns-in-the-treatment-of-schizophrenia-124393https://curecurrent.com/trials/28-30-month-study-comparing-paliperidone-palmitate-with-oral-risperidone-for-treating-adults-diagnosed-with-schizophreni-124394https://curecurrent.com/trials/a-double-blind-controlled-study-of-aripiprazole-in-co-morbid-schizophrenia-and-cocaine-dependence-124395https://curecurrent.com/trials/aripiprazole-open-label-safety-and-tolerability-study-124396https://curecurrent.com/trials/the-paliperidone-er-observational-study-of-economic-functional-and-clinical-outcomes-in-patients-with-schizophrenia-124397https://curecurrent.com/trials/clinical-benefits-of-seroquel-xr-in-anxiety-disorder-124398https://curecurrent.com/trials/multicenter-open-label-randomised-haloperidol-controlled-study-to-evaluate-seroquel-as-mono-therapy-in-the-treatment-of-124399https://curecurrent.com/trials/the-third-survey-of-prescription-pattern-of-psychotropic-drugs-in-china-124400https://curecurrent.com/trials/internalized-stigma-in-patients-with-bipolar-disorder-or-schizophrenia-124401https://curecurrent.com/trials/improving-insight-in-patients-diagnosed-with-schizophrenia-124402https://curecurrent.com/trials/aripiprazole-in-adolescents-with-schizophrenia-124403https://curecurrent.com/trials/family-intervention-for-mental-illness-and-substance-abuse-124404https://curecurrent.com/trials/a-comparison-of-risperidone-with-haloperidol-in-patients-with-schizophrenia-and-schizoaffective-disorder-124405https://curecurrent.com/trials/schizophrenia-imaging-124406https://curecurrent.com/trials/schizophrenic-patients-in-integrated-care-124407https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-armodafinil-as-adjunctive-therapy-in-adults-with-schizophrenia-124408https://curecurrent.com/trials/compare-the-effect-on-cognitive-functioning-of-two-formulations-of-seroquel-seroquel-xr-and-ir-in-patients-with-stable-s-124409https://curecurrent.com/trials/bexarotene-augmentation-of-antipsychotic-treatment-for-chronic-schizophrenia-124410https://curecurrent.com/trials/seroquel-xr-in-adults-with-schizophrenia-124411https://curecurrent.com/trials/impact-of-genetic-counseling-for-individuals-with-mental-illness-124412https://curecurrent.com/trials/24-hour-time-course-of-striatal-dopamine-d2-receptor-occupancy-of-ziprasidone-a-pet-study-124413https://curecurrent.com/trials/tetrabenazine-for-partial-responders-124414https://curecurrent.com/trials/steady-state-bioequivalence-study-of-torrent-pharmaceuticals-ltd-s-bioequivalence-study-of-torrent-pharmaceuticals-ltd-s-124415https://curecurrent.com/trials/gene-promoter-dna-methylations-and-their-relationships-with-endophenotypes-in-patients-with-schizophrenia-124416https://curecurrent.com/trials/study-evaluating-the-clinical-benefit-of-seroquel-xr-in-subjects-with-schizophrenia-124417https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-evp-6124-in-patients-with-schizophrenia-124418https://curecurrent.com/trials/quetiapine-extended-release-depression-symptoms-124419https://curecurrent.com/trials/d-serine-for-enhancing-cognitive-retraining-for-the-treatment-of-schizophrenia-124420https://curecurrent.com/trials/schizophrenia-and-physical-exercise-124421https://curecurrent.com/trials/efficacy-study-of-switching-stabilized-schizophrenic-patients-from-conventional-to-atypical-antipsychotic-treatment-124422https://curecurrent.com/trials/computer-assisted-cognitive-remediation-program-in-schizophrenia-124423https://curecurrent.com/trials/evaluation-of-the-strategies-of-switching-schizophrenia-patients-to-aripiprazole-from-other-antipsychotic-agents-124424https://curecurrent.com/trials/efficacy-and-safety-of-quetiapine-fumarate-in-the-treatment-of-schizophrenic-patients-124425https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-of-repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-negativ-124426https://curecurrent.com/trials/nicotinic-modulation-of-schizophrenia-like-information-processing-deficits-in-healthy-subjects-124427https://curecurrent.com/trials/allopurinol-in-schizophrenia-a-randomized-trial-administering-allopurinol-vs-placebo-as-add-on-antipsychotics-in-patient-124428https://curecurrent.com/trials/treat-clozapine-clz-resistant-schizophrenia-comparing-clz-haloperidol-vs-clz-electroconvulsive-therapy-ect-124429https://curecurrent.com/trials/cognitive-therapy-for-negative-symptoms-and-functioning-124430https://curecurrent.com/trials/a-study-to-assess-the-relative-bioavailability-of-a-modified-release-formulation-of-pf-05180999-124431https://curecurrent.com/trials/an-observational-study-to-assess-treatment-outcomes-data-in-patients-receiving-long-acting-injectable-risperidone-124432https://curecurrent.com/trials/smoking-abstinence-and-lapse-effects-in-smokers-with-schizophrenia-and-controls-124433https://curecurrent.com/trials/dose-response-study-to-evaluate-safety-efficacy-and-pharmacokinetics-of-pf-00217830-compared-with-placebo-in-acute-exace-124434https://curecurrent.com/trials/a-study-of-zonisamide-to-prevent-olanzapine-associated-weight-gain-124435https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacokinetics-of-single-doses-of-pf-05180999-in-healthy-adults-124436https://curecurrent.com/trials/the-pharmaco-genetic-and-brain-mechanisms-associated-with-cannabis-induced-psychosis-124437https://curecurrent.com/trials/effect-of-antipsychotics-on-appetite-regulation-124438https://curecurrent.com/trials/glycine-treatment-of-prodromal-symptoms-124439https://curecurrent.com/trials/glucose-as-a-mediator-of-self-control-performances-in-patients-with-schizophrenia-124440https://curecurrent.com/trials/minocycline-augmentation-in-schizophrenia-124441https://curecurrent.com/trials/the-effect-of-nicotine-on-arousal-cognition-and-social-cognition-in-young-and-elderly-healthy-subjects-124442https://curecurrent.com/trials/histamine-h2-antagonism-as-adjuvant-therapy-in-treatment-resistant-schizophrenia-124443https://curecurrent.com/trials/the-effect-of-nicotine-on-arousal-cognition-and-social-cognition-in-schizophrenic-patients-124444https://curecurrent.com/trials/change-in-brain-bioenergetics-in-bipolar-disorder-in-response-to-photic-stimulation-124445https://curecurrent.com/trials/magnetoencephalographic-meg-evidence-for-novel-metaphor-processing-among-schizophrenic-patients-124446https://curecurrent.com/trials/add-on-sodium-nitroprusside-to-treatment-as-usual-in-schizophrenia-124447https://curecurrent.com/trials/cognitive-remediation-in-early-phase-psychosis-124448https://curecurrent.com/trials/the-psychiatric-rehabilitation-approach-to-weight-loss-124449https://curecurrent.com/trials/a-study-of-olanzapine-in-patients-with-schizophrenia-124450https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-memantine-as-adjunctive-treatment-in-schizophrenia-patients-124451https://curecurrent.com/trials/social-cognition-attentional-network-and-nicotine-drug-dependency-a-pharmacological-clinical-trail-124452https://curecurrent.com/trials/artemisinin-to-reduce-the-symptoms-of-schizophrenia-124453https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-first-episode-schizophrenia-patients-124454https://curecurrent.com/trials/an-epidemiological-study-to-assess-the-psychosocial-and-symptomatic-remission-and-community-integration-status-in-patien-124455https://curecurrent.com/trials/effect-of-genotyping-for-cyp450-polymorphisms-versus-intense-clinical-monitoring-on-antipsychotic-drug-treatment-124456https://curecurrent.com/trials/effects-of-cariprazine-on-cardiac-repolarization-in-patients-with-schizophrenia-124457https://curecurrent.com/trials/a-study-of-pf-03463275-as-add-on-therapy-in-outpatients-with-persistent-negative-symptoms-of-schizophrenia-124458https://curecurrent.com/trials/efficacy-and-safety-of-two-atypical-antipsychotics-vs-placebo-in-patients-with-an-acute-exacerbation-of-either-schizophr-124459https://curecurrent.com/trials/olanzapine-pamoate-depot-versus-oral-olanzapine-on-treatment-outcomes-in-outpatients-with-schizophrenia-124460https://curecurrent.com/trials/schizophrenia-related-troubles-and-glutathione-clinical-trial-effects-of-oral-administration-of-n-acetylcysteine-nac-on-124461https://curecurrent.com/trials/evaluation-of-the-effects-of-treatment-of-psycho-stimulant-and-cannabis-dependent-users-in-israel-124462https://curecurrent.com/trials/treatment-for-first-episode-schizophrenia-124463https://curecurrent.com/trials/open-label-study-of-intramuscular-olanzapine-depot-in-patients-with-schizophrenia-or-schizoaffective-disorder-124464https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-refractory-auditory-hallucinations-in-schizophrenia-124465https://curecurrent.com/trials/minocycline-as-an-adjunctive-therapy-for-schizophrenia-a-randomized-controlled-study-124466https://curecurrent.com/trials/tolerability-safety-and-efficacy-of-the-h1-coil-deep-transcranial-magnetic-stimulation-in-subjects-with-negative-symptom-124467https://curecurrent.com/trials/magnetoencephalographic-meg-correlates-of-negative-symptoms-in-patients-suffering-from-schizophrenia-and-their-influence-124468https://curecurrent.com/trials/chronic-cannabis-users-a-model-for-negative-symptoms-in-schizophrenia-124469https://curecurrent.com/trials/body-movement-imitation-and-perspective-perception-among-psychiatric-patients-124470https://curecurrent.com/trials/critical-time-intervention-in-the-transition-from-hospital-to-community-in-people-with-severe-mental-illness-124471https://curecurrent.com/trials/evaluation-of-effectiveness-of-risperdal-consta-compared-to-abilify-over-a-two-year-period-in-patients-with-schizophreni-124472https://curecurrent.com/trials/evaluation-of-generalization-paradigm-patterns-among-different-psychiatric-disorders-124473https://curecurrent.com/trials/paliperidone-extended-release-er-versus-risperidone-for-neurocognitive-function-in-patients-with-schizophrenia-124474https://curecurrent.com/trials/the-study-of-minocycline-for-negative-and-cognitive-symptoms-in-schizophrenia-124475https://curecurrent.com/trials/unraveling-the-relation-of-patient-s-profile-and-therapeutical-effects-of-atypicals-including-quetiapine-effect-124476https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-of-donepezil-adjunctive-treatment-for-cognitive-impairment-in-schizophrenia-124477https://curecurrent.com/trials/effects-of-exposed-to-antipsychotics-throughout-pregnancy-on-infants-development-a-prospective-study-124478https://curecurrent.com/trials/impact-of-genetic-counseling-for-female-first-degree-relatives-of-individuals-with-mental-illness-124479https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-quetiapine-fumarate-extended-release-seroquel-xr-124480https://curecurrent.com/trials/prevalence-of-metabolic-syndrome-in-patients-with-schizophrenia-in-korea-124481https://curecurrent.com/trials/quetiapine-xr-in-schizophrenic-patients-124482https://curecurrent.com/trials/hematological-clozapine-monitoring-with-a-point-of-care-device-chempaq-124483https://curecurrent.com/trials/the-effects-azd8529-on-cognition-and-negative-symptoms-in-schizophrenics-124484https://curecurrent.com/trials/observational-study-to-evaluate-bipolar-disorder-symptoms-in-patients-presented-with-schizophrenia-or-depression-124485https://curecurrent.com/trials/high-dose-d-serine-as-adjuvant-treatment-for-recent-onset-schizophrenia-124486https://curecurrent.com/trials/quetiapine-induced-neuroplasticity-in-first-episode-schizophrenic-patients-124487https://curecurrent.com/trials/seroquel-xr-in-the-long-term-treatment-of-schizophrenia-124488https://curecurrent.com/trials/gamma-amino-butyric-acid-gaba-a-alpha2-3-study-124489https://curecurrent.com/trials/nis-to-observe-improvement-in-global-assessment-of-functioning-in-patients-with-schizophrenia-124490https://curecurrent.com/trials/study-of-a-neurocognition-enhancing-agent-in-patients-with-schizophrenia-124491https://curecurrent.com/trials/non-interventional-open-label-study-to-investigate-the-effect-of-quetiapine-xr-on-patient-satisfaction-and-quality-of-li-124492https://curecurrent.com/trials/the-campus-project-cholinergic-augmentation-of-cognitive-deficits-in-schizophrenia-124493https://curecurrent.com/trials/dopaminergic-functional-structural-and-cognitive-disturbances-in-first-episode-schizophrenia-124494https://curecurrent.com/trials/neurobiological-and-neurocognitive-disturbances-in-first-episode-schizophrenia-124495https://curecurrent.com/trials/aripiprazole-in-the-treatment-of-patients-with-schizophrenia-and-symptoms-of-obsessive-compulsive-disorder-ocd-124496https://curecurrent.com/trials/effect-of-calories-and-fat-content-on-the-pharmacokinetics-of-lurasidone-hcl-124497https://curecurrent.com/trials/midazolam-drug-drug-interaction-study-with-lurasidone-hcl-124498https://curecurrent.com/trials/lithium-drug-drug-interaction-study-with-lurasidone-hcl-124499https://curecurrent.com/trials/the-bioequivalence-of-two-different-lurasidone-formulations-in-patients-124500https://curecurrent.com/trials/digoxin-drug-drug-interaction-with-lurasidone-hcl-124501https://curecurrent.com/trials/cognitive-improvement-with-aripiprazole-abilify-in-patients-with-schizophrenia-bms-124502https://curecurrent.com/trials/cognitive-improvement-with-aripiprazole-abilify-in-patients-with-schizophrenia-sfbri-124503https://curecurrent.com/trials/epidemiology-study-of-psychosis-124504https://curecurrent.com/trials/effects-of-seroquel-xr-on-the-improvement-of-neurocognitive-function-in-people-at-risk-mental-states-arms-124505https://curecurrent.com/trials/safety-study-of-sertindole-versus-risperidone-under-normal-conditions-of-use-124506https://curecurrent.com/trials/effectiveness-of-atypical-antipsychotics-on-anhedonic-features-in-patients-with-schizophrenia-124507https://curecurrent.com/trials/clinical-intervention-psychosis-and-addiction-124508https://curecurrent.com/trials/exercise-and-diet-program-for-schizophrenia-patients-who-are-taking-atypical-antipsychotic-medications-124509https://curecurrent.com/trials/specialized-clozapine-clinic-for-bipolar-and-schizoaffective-disorder-124510https://curecurrent.com/trials/omega-3-fatty-acid-deficiency-replacement-in-early-schizophrenia-124511https://curecurrent.com/trials/magnetic-stimulation-as-a-treatment-for-auditory-hallucinations-in-schizophrenia-124512https://curecurrent.com/trials/treatment-strategy-for-refractory-schizophrenia-drug-interaction-between-clozapine-and-fluvoxamine-124513https://curecurrent.com/trials/effects-of-atypical-antipsychotics-on-appetite-and-eating-behavior-of-schizophrenia-patients-124514https://curecurrent.com/trials/measurments-of-bbb-breakdown-in-the-pathogenesis-of-psychiatric-disorders-124515https://curecurrent.com/trials/d-amino-acid-oxidase-inhibition-daaoi-1-add-on-treatment-for-chronic-schizophrenia-124516https://curecurrent.com/trials/a-follow-up-study-of-intramuscular-olanzapine-depot-in-patients-with-schizophrenia-or-schizoaffective-disorder-124517https://curecurrent.com/trials/psychopathology-of-dissociative-disorders-124518https://curecurrent.com/trials/a-placebo-controlled-single-dose-trial-of-sildenafil-in-schizophrenia-124519https://curecurrent.com/trials/safety-study-of-acp-104-to-demonstrate-the-safety-tolerability-and-pharmacokinetics-124520https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-topiramate-compared-to-placebo-in-the-treatment-of-patients-with-bip-124521https://curecurrent.com/trials/the-compliance-project-concerning-people-with-schizophrenia-124522https://curecurrent.com/trials/evaluation-of-dorsal-visual-stream-in-patients-with-schizophrenia-124523https://curecurrent.com/trials/efficacy-and-safety-of-quetiapine-in-treating-affective-symptoms-of-patients-with-first-episode-psychosis-a-pilot-study-124524https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-of-er-oros-paliperidone-in-volunteers-with-normal-or-impaired-renal-function-124525https://curecurrent.com/trials/a-study-of-dopamine-type-2-d2-receptor-occupancy-following-a-single-oral-dose-of-oros-paliperidone-124526https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-three-fixed-doses-of-extended-release-paliperidone-in-subjects-with-bipol-124527https://curecurrent.com/trials/a-comparison-of-the-pharmacokinetics-and-safety-of-long-acting-injectable-risperidone-when-administered-to-gluteal-or-de-124528https://curecurrent.com/trials/a-long-term-study-of-long-acting-injectable-risperidone-in-the-treatment-of-patients-with-schizophrenia-124529https://curecurrent.com/trials/trial-evaluating-three-fixed-doses-of-paliperidone-extended-release-er-tablets-and-olanzapine-in-the-treatment-of-patien-124530https://curecurrent.com/trials/a-52-week-open-label-extension-trial-following-the-double-blind-efficacy-and-safety-study-r076477-sch-305-124531https://curecurrent.com/trials/safety-study-with-paliperidone-er-extended-release-er-tablets-in-geriatric-patients-with-schizophrenia-124532https://curecurrent.com/trials/a-pharmacokinetics-and-pharmacodynamics-study-under-fasting-and-fed-conditions-with-paliperidone-extended-release-and-im-124533https://curecurrent.com/trials/a-study-of-the-potential-effects-of-trimethoprim-on-the-pharmacokinetics-of-er-oros-paliperidone-124534https://curecurrent.com/trials/as-study-of-the-pharmacokinetics-of-paliperidone-extended-release-and-risperidone-immediate-release-formulations-124535https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-topiramate-in-the-treatment-of-patients-with-bipolar-disorder-124536https://curecurrent.com/trials/study-of-cyr-101-in-patients-with-schizophrenia-124537https://curecurrent.com/trials/a-pharmacokinetics-and-pharmacodynamics-study-under-fasting-and-fed-conditions-with-paliperidone-extended-release-and-im-124538https://curecurrent.com/trials/a-study-of-plasma-concentrations-metabolism-and-excretion-of-14c-paliperidone-after-a-single-oral-dose-124539https://curecurrent.com/trials/the-efficacy-and-safety-of-risperidone-in-the-treatment-of-adolescents-with-schizophrenia-124540https://curecurrent.com/trials/a-study-of-qt-and-qtc-intervals-in-patients-administered-immediate-release-paliperidone-124541https://curecurrent.com/trials/a-study-of-effectiveness-and-safety-of-paliperidone-extended-release-er-tablets-in-the-prevention-of-recurrence-in-adult-124542https://curecurrent.com/trials/a-bioequivalence-study-of-15-mg-er-oros-paliperidone-124543https://curecurrent.com/trials/investigate-risperidone-for-the-treatment-of-schizophrenia-in-adolescents-124544https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-and-safety-of-3-doses-of-paliperidone-palmitate-in-treating-subjects-with-schizoph-124545https://curecurrent.com/trials/a-study-of-paliperidone-enantiomer-disposition-with-different-formulations-and-the-bioavailability-of-immediate-and-exte-124546https://curecurrent.com/trials/a-study-of-the-effect-of-food-on-the-pharmacokinetics-of-er-oros-paliperidone-in-healthy-japanese-volunteers-124547https://curecurrent.com/trials/a-52-week-open-label-extension-study-following-a-6-week-double-blind-placebo-and-active-controlled-study-r076477-sch-303-124548https://curecurrent.com/trials/a-study-comparing-the-efficacy-of-long-acting-injectable-risperidone-and-olanzapine-tablets-in-the-treatment-of-patients-124549https://curecurrent.com/trials/24-week-open-label-extension-to-a-randomized-6-week-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-tol-124550https://curecurrent.com/trials/a-study-to-compare-the-effectiveness-and-safety-of-flexibly-varied-doses-of-paliperidone-palmitate-and-risperidone-in-tr-124551https://curecurrent.com/trials/a-study-of-extended-release-extended-release-er-oros-paliperidone-tolerability-as-compared-to-immediate-release-ir-rispe-124552https://curecurrent.com/trials/trial-evaluating-the-efficacy-and-safety-of-2-fixed-doses-of-paliperidone-extended-release-er-tablets-in-the-treatment-o-124553https://curecurrent.com/trials/trial-evaluating-three-fixed-dosages-of-paliperidone-extended-release-er-tablets-and-olanzapine-in-the-treatment-of-pati-124554https://curecurrent.com/trials/a-safety-and-pharmacokinetic-study-of-er-oros-paliperidone-in-pediatric-patients-with-schizophrenia-schizoaffective-diso-124555https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-of-paliperidone-in-volunteers-with-normal-or-impaired-liver-function-124556https://curecurrent.com/trials/a-52-week-open-label-extension-trial-following-the-recurrence-prevention-study-r076477-sch-301-to-evaluate-the-safety-an-124557https://curecurrent.com/trials/efficacy-and-safety-of-a-long-acting-anti-psychotic-versus-placebo-in-patients-with-schizophrenia-124558https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-in-the-treatment-of-adolescents-with-schizophrenia-124559https://curecurrent.com/trials/a-safety-and-tolerability-study-of-paliperidone-palmitate-injected-in-the-shoulder-or-the-buttock-muscle-in-patients-wit-124560https://curecurrent.com/trials/study-evaluating-and-comparing-single-dose-and-multiple-dose-pharmacokinetics-of-er-oros-paliperidone-in-healthy-japanes-124561https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-galantamine-hydrobromide-on-cognitive-impairment-in-patients-with-schizophren-124562https://curecurrent.com/trials/a-dose-proportionality-study-of-five-tablet-strengths-of-er-oros-paliperidone-124563https://curecurrent.com/trials/safety-and-efficacy-of-an-anti-psychotic-in-patients-with-schizophrenia-124564https://curecurrent.com/trials/expanding-rapid-ascertainment-networks-of-schizophrenia-families-in-taiwan-124565https://curecurrent.com/trials/study-on-the-safety-and-effectiveness-of-risperidone-treatment-of-acute-psychotic-patients-124566https://curecurrent.com/trials/a-randomized-active-controlled-double-blind-parallel-goup-study-of-the-efficacy-and-safety-of-extended-release-er-palipe-124567https://curecurrent.com/trials/a-study-of-the-effects-of-paroxetine-on-the-pharmacokinetics-of-paliperidone-er-124568https://curecurrent.com/trials/adh-e-r-e-therapeutic-adherence-and-treatment-strategies-a-mental-health-registry-124569https://curecurrent.com/trials/topiramate-versus-placebo-as-add-on-treatment-in-patients-with-bipolar-disorder-in-the-outpatient-setting-124570https://curecurrent.com/trials/profile3-epidemiologic-survey-in-patients-with-schizophrenia-or-schizoaffective-disorders-124571https://curecurrent.com/trials/evaluation-of-effectiveness-and-safety-of-paliperidone-er-extended-release-compared-with-quetiapine-in-patients-with-sch-124572https://curecurrent.com/trials/a-study-of-the-dose-proportionality-of-extended-release-paliperidone-124573https://curecurrent.com/trials/injection-site-tolerability-of-multiple-dose-treatment-with-long-acting-injectable-risperidone-administered-via-deltoid-124574https://curecurrent.com/trials/a-study-of-the-long-term-safety-and-tolerability-and-the-long-term-effectiveness-of-extended-release-oral-paliperidone-i-124575https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-adjustable-doses-of-extended-release-er-paliperidone-compared-with-placeb-124576https://curecurrent.com/trials/evaluation-of-the-usefulness-to-doctors-of-the-risperdal-consta-treatment-guidebook-over-a-three-month-period-during-whi-124577https://curecurrent.com/trials/a-study-of-the-effect-of-carbamazepine-on-the-pharmacokinetics-of-paliperidone-extended-release-er-in-patients-with-schi-124578https://curecurrent.com/trials/a-study-of-how-long-it-takes-a-patient-to-relapse-after-switching-from-an-oral-antipsychotic-to-one-of-two-doses-of-long-124579https://curecurrent.com/trials/a-pharmacokinetic-study-of-the-relative-bioavailability-of-paliperidone-er-formulations-with-different-release-profiles-124580https://curecurrent.com/trials/a-study-of-the-effect-of-food-and-posture-on-the-pharmacokinetics-of-a-single-dose-of-er-oros-paliperidone-124581https://curecurrent.com/trials/a-study-of-the-bioequivalence-of-12-mg-paliperidone-extended-release-tablets-manufactured-at-gurabo-and-vacaville-124582https://curecurrent.com/trials/a-study-of-qt-and-qtc-intervals-in-patients-administered-extended-release-paliperidone-or-quetiapine-124583https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-risperidone-injections-given-once-a-month-to-adults-with-schizophrenia-or-schiz-124584https://curecurrent.com/trials/a-long-term-safety-study-for-long-acting-injectable-risperidone-in-schizophrenia-or-schizoaffective-disorder-patients-124585https://curecurrent.com/trials/a-pharmacokinetic-and-safety-study-of-risperidone-long-acting-injectable-in-schizophrenic-patients-124586https://curecurrent.com/trials/a-2-year-study-of-patients-with-schizophrenia-who-are-treated-with-long-acting-injectable-risperidone-124587https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-long-acting-injectable-risperidone-and-risperidone-tablets-in-patients-with-schizo-124588https://curecurrent.com/trials/an-exploratory-study-on-the-safety-and-effectiveness-of-paliperidone-in-patients-with-schizophrenia-124589https://curecurrent.com/trials/treatment-with-risperidone-long-acting-injectable-rlai-in-an-early-phase-of-psychosis-124590https://curecurrent.com/trials/a-long-term-study-of-safety-for-long-acting-injectable-risperidone-in-patients-with-schizophrenia-or-schizoaffective-dis-124591https://curecurrent.com/trials/mental-health-related-to-school-dropout-in-luxembourg-124592https://curecurrent.com/trials/study-of-amantadine-for-weight-stabilization-during-olanzapine-treatment-124593https://curecurrent.com/trials/add-on-treatment-for-cognitive-deficits-in-schizophrenia-124594https://curecurrent.com/trials/an-evaluation-of-the-safety-and-efficacy-of-abt-925-in-subjects-with-acute-exacerbation-of-schizophrenia-124595https://curecurrent.com/trials/neuromodulation-in-depressed-and-schizophrenic-patients-changing-mep-muscle-evoked-potentials-by-tdcs-transcranial-direc-124596https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-study-of-pf-03463275-in-healthy-male-japanese-and-western-subjects-124597https://curecurrent.com/trials/efficacy-and-safety-of-nbi-98854-in-subjects-with-tardive-dyskinesia-124598https://curecurrent.com/trials/feasibility-of-providing-cognitive-remediation-to-people-with-schizophrenia-in-a-clinical-network-124599https://curecurrent.com/trials/smoking-cessation-study-for-patients-with-schizophrenia-or-schizoaffective-disorder-124600https://curecurrent.com/trials/v3-vancouver-victoria-valacyclovir-trial-for-early-psychosis-124601https://curecurrent.com/trials/comparison-of-clozapine-vs-olanzapine-in-childhood-onset-psychotic-disorders-124602https://curecurrent.com/trials/effects-of-gene-polymorphisms-on-metabolic-features-in-clozapine-treated-patients-with-schizophrenia-124603https://curecurrent.com/trials/minocycline-acetylsalicylic-acid-or-pramipexole-vs-placebo-in-patients-with-schizophrenia-or-schizoaffective-disorder-124604https://curecurrent.com/trials/a-retrospective-nis-to-evaluate-the-use-of-seroquel-xr-and-ir-in-the-clinical-practice-of-outpatients-with-schizophrenia-124605https://curecurrent.com/trials/reboxetine-and-citalopram-as-an-adjunct-treatment-to-second-generation-antipsychotics-in-the-treatment-of-negative-sympt-124606https://curecurrent.com/trials/antipsychotic-therapy-and-first-episode-124607https://curecurrent.com/trials/nis-register-study-comparing-seroquel-and-seroquel-prolong-124608https://curecurrent.com/trials/amantadine-as-adjunctive-therapy-to-antipsychotics-in-schizophrenia-124609https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-compared-with-haloperidol-and-placebo-in-patients-with-chronic-sc-124610https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-compared-with-haloperidol-in-patients-with-chronic-schizophrenia-124611https://curecurrent.com/trials/a-study-evaluating-the-treatment-selection-and-outcome-when-changing-antipsychotic-treatment-in-schizophrenic-patients-124612https://curecurrent.com/trials/dose-finding-of-quetiapine-fumarate-200mg-vs-400mg-in-first-episode-psychosis-124613https://curecurrent.com/trials/fast-titration-of-quetiapine-versus-currently-approved-titration-124614https://curecurrent.com/trials/specialized-addiction-treatment-versus-treatment-as-usual-for-young-patients-with-cannabis-abuse-and-psychosis-124615https://curecurrent.com/trials/raloxifene-in-treatment-of-schizophrenia-and-schizoaffective-disorder-124616https://curecurrent.com/trials/clozapine-paliperidone-versus-clozapine-placebo-in-resistant-schizophrenia-124617https://curecurrent.com/trials/a-study-of-risperidone-in-combination-with-lorazepam-compared-with-standard-therapy-for-emergency-treatment-of-schizophr-124618https://curecurrent.com/trials/a-comparison-of-the-effectiveness-and-safety-of-injectable-risperidone-with-that-of-risperidone-tablets-in-the-treatment-124619https://curecurrent.com/trials/a-retrospective-non-interventional-study-to-evaluate-the-use-of-seroquel-extended-release-xr-and-immediate-release-ir-in-124620https://curecurrent.com/trials/a-study-to-assess-safety-and-tolerabiltiy-associated-with-a-switch-from-oral-antipsychotic-medications-to-long-acting-in-124621https://curecurrent.com/trials/non-interventional-ni-study-to-observe-efficacy-and-usage-of-quetiapine-in-acute-episodes-of-schizophrenia-and-as-mainte-124622https://curecurrent.com/trials/treatment-of-schizophrenia-with-an-omega-3-fatty-acid-epa-and-antioxidants-124623https://curecurrent.com/trials/study-evaluating-the-safety-and-tolerability-of-htc-867-in-healthy-japanese-subjects-124624https://curecurrent.com/trials/pregnenolone-augmentation-in-the-treatment-of-patients-with-recent-onset-schizophrenia-124625https://curecurrent.com/trials/efficacy-and-safety-of-ziprasidone-to-treat-depressive-symptoms-in-patients-with-schizophrenia-124626https://curecurrent.com/trials/observation-of-change-in-clinical-global-impression-scores-in-schizophrenia-patients-receiving-seroquel-xr-treatment-124627https://curecurrent.com/trials/fast-a-study-to-evaluate-the-efficacy-and-safety-of-quetiapin-ir-in-patients-with-acute-psychosis-124628https://curecurrent.com/trials/spanish-validation-of-tool-questionnaire-to-assess-patients-perception-about-antipsychotic-treatment-124629https://curecurrent.com/trials/validity-of-the-spanish-version-of-subjective-well-being-under-neuroleptics-scale-swn-k-in-patients-with-schizophrenia-124630https://curecurrent.com/trials/four-dimensions-in-schizophrenia-124631https://curecurrent.com/trials/schizophrenic-patients-taking-part-in-integrated-care-program-124632https://curecurrent.com/trials/observational-study-to-evaluate-efficacy-and-remission-status-for-schizophrenia-patients-under-atypical-treatment-124633https://curecurrent.com/trials/efficacy-study-on-cognitive-functions-in-schizophrenic-patients-124634https://curecurrent.com/trials/a-non-interventional-naturalistic-project-to-investigate-the-effect-of-the-use-of-sms-text-service-on-treatment-adherenc-124635https://curecurrent.com/trials/safety-and-efficacy-of-switching-to-quetiapine-in-outpatients-with-schizophrenia-124636https://curecurrent.com/trials/subjective-well-being-of-schizophrenic-patients-in-greece-124637https://curecurrent.com/trials/adherence-in-adolescents-and-children-treated-on-quetiapine-124638https://curecurrent.com/trials/efficacy-and-safety-study-of-escitalopram-augmentation-in-treatment-resistant-schizophrenia-124639https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intramuscular-levosulpiride-in-patients-with-agitation-of-schizophrenia-124640https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-long-acting-injectable-risperidone-versus-placebo-in-the-treatment-of-patient-124641https://curecurrent.com/trials/expanding-rapid-ascertainment-network-of-schizophrenia-families-in-taiwan-124642https://curecurrent.com/trials/polypharmacy-in-clozapine-resistant-schizophrenia-124643https://curecurrent.com/trials/a-study-of-long-acting-injectable-risperidone-in-the-treatment-of-patients-with-schizophrenia-or-schizoaffective-disorde-124644https://curecurrent.com/trials/seroquel-xr-in-schizophrenia-relapse-prevention-124645https://curecurrent.com/trials/assessing-the-effectiveness-of-acceptance-and-commitment-therapy-for-distress-following-psychosis-124646https://curecurrent.com/trials/pharmacokinetic-study-of-abt-126-in-stable-subjects-with-schizophrenia-124647https://curecurrent.com/trials/contrasting-the-brain-effects-of-risperidone-and-invega-with-functional-magnetic-resonance-imaging-fmri-and-positron-emi-124648https://curecurrent.com/trials/evaluating-subjective-well-being-in-schizophrenic-patients-treated-with-quetiapinexr-and-other-atypical-antipsychotics-124649https://curecurrent.com/trials/rispect-risperdal-safety-protocol-evaluation-consta-treatment-a-post-authorization-safety-survey-to-obtain-information-o-124650https://curecurrent.com/trials/evaluation-of-single-and-repeat-doses-of-gsk729327-in-healthy-volunteers-124651https://curecurrent.com/trials/augmenting-clozapine-with-sertindole-sercloz-124652https://curecurrent.com/trials/efficacy-of-bifeprunox-in-patients-with-schizophrenia-124653https://curecurrent.com/trials/efficacy-of-bifeprunox-in-patients-with-schizophrenia-124654https://curecurrent.com/trials/study-in-schizophrenic-in-patients-treated-with-quetiapine-prolong-or-oral-risperidone-at-flexible-dose-124655https://curecurrent.com/trials/optimal-duration-of-early-intervention-for-psychosis-124656https://curecurrent.com/trials/a-clinical-trial-to-examine-effects-of-atomoxetine-in-the-treatment-of-negative-symptoms-in-patients-with-schizophrenia-124657https://curecurrent.com/trials/entacapone-augmentation-for-schizophrenia-124658https://curecurrent.com/trials/reduction-of-cardiovascular-risk-in-severe-mental-illness-124659https://curecurrent.com/trials/a-pilot-double-blind-sham-controlled-trial-of-repetitive-transcranial-magnetic-stimulation-for-patients-with-refractory-124660https://curecurrent.com/trials/outcome-evaluation-of-solutions-for-wellness-and-team-solutions-program-in-patients-with-severe-mental-illness-124661https://curecurrent.com/trials/study-to-asses-pharmacodynamics-pharmacokinetics-safety-and-tolerability-of-azd0328-in-patients-with-schizophrenia-124662https://curecurrent.com/trials/the-effect-of-ketamine-on-attentiveness-124663https://curecurrent.com/trials/efficacy-and-safety-of-psychopharmacotherapy-in-patients-with-schizophrenia-or-bipolar-disorders-124664https://curecurrent.com/trials/the-effect-of-cigarette-holders-plastic-menthol-cigarettes-and-cognitive-behavioral-therapy-for-smoking-reduction-among-124665https://curecurrent.com/trials/family-motivational-intervention-in-schizophrenia-124666https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-long-acting-risperidone-microspheres-in-patients-with-schizophrenia-or-other-psycho-124667https://curecurrent.com/trials/efficacy-and-safety-with-ziprasidone-in-first-episode-psychosis-124668https://curecurrent.com/trials/study-to-assess-the-efficacy-safety-and-tolerability-of-azd8529-in-adult-schizophrenia-patients-124669https://curecurrent.com/trials/a-six-week-randomized-double-blind-placebo-controlled-parallel-group-multi-center-phase-ii-study-124670https://curecurrent.com/trials/bexarotene-and-fenretinide-as-addition-to-antipsychotic-treatment-in-schizophrenia-patients-124671https://curecurrent.com/trials/extension-study-to-evaluate-the-long-term-safety-tolerability-and-efficacy-of-low-and-high-doses-of-bl-1020-124672https://curecurrent.com/trials/attention-and-visual-perception-in-schizophrenia-a-functional-magnetic-resonance-imaging-fmri-study-124673https://curecurrent.com/trials/microglia-activation-in-schizophrenia-124674https://curecurrent.com/trials/effect-of-olanzapine-on-sleep-electroencephalogram-eeg-in-schizophrenia-patients-124675https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-seroquel-in-chinese-han-patients-with-schizophrenia-124676https://curecurrent.com/trials/quality-of-life-in-schizophrenic-patients-124677https://curecurrent.com/trials/paternal-psychosis-after-baby-born-124678https://curecurrent.com/trials/use-effects-and-side-effects-of-second-generation-antipsychotics-in-a-naturalistic-setting-124679https://curecurrent.com/trials/remediation-of-schizophrenia-sensory-gating-deficit-with-aripiprazole-124680https://curecurrent.com/trials/trial-evaluating-paliperidone-extended-release-er-tablets-versus-placebo-on-sleep-in-schizophrenia-patients-124681https://curecurrent.com/trials/promoting-adherence-to-treatment-in-schizophrenia-124682https://curecurrent.com/trials/clozapine-and-olanzapine-treatment-of-aggression-124683https://curecurrent.com/trials/positron-emission-tomagraphy-pet-study-following-a-single-oral-dose-of-opc-34712-124684https://curecurrent.com/trials/evaluation-of-the-h1-coil-deep-tms-in-the-treatment-of-negative-symptoms-and-cognitive-deficit-in-schizophrenia-124685https://curecurrent.com/trials/safety-study-of-olanzapine-and-a-comparator-in-patients-with-schizophrenia-and-schizoaffective-disorder-124686https://curecurrent.com/trials/intramuscular-injections-of-paliperidone-palmitate-in-the-arm-or-buttock-of-subjects-with-schizophrenia-124687https://curecurrent.com/trials/a-study-to-evaluate-symptomatic-remission-in-schizophrenia-with-long-acting-risperidone-microspheres-124688https://curecurrent.com/trials/a-study-comparing-three-strategies-to-switch-patients-with-schizophrenia-or-schizoaffective-disorder-to-risperidone-afte-124689https://curecurrent.com/trials/a-registry-of-treatment-adherence-for-patients-with-schizophrenia-124690https://curecurrent.com/trials/a-study-of-paliperidone-blood-concentrations-in-patients-with-schizophrenia-after-administration-of-paliperidone-palmita-124691https://curecurrent.com/trials/an-open-label-study-evaluating-the-maintenance-of-clinical-effect-in-adult-schizophrenia-patients-switched-from-risperid-124692https://curecurrent.com/trials/bioequivalence-study-comparing-2-formulations-for-4-mg-risperidone-tablet-124693https://curecurrent.com/trials/zotepine-versus-risperidone-in-aggressive-schizophrenic-patients-of-acute-ward-124694https://curecurrent.com/trials/amisulpride-augmentation-therapy-for-clozapine-resistant-schizophrenic-patients-124695https://curecurrent.com/trials/the-pharmacogenetic-study-readiness-to-change-and-pharmacological-intervention-for-smoking-cessation-in-schizophrenia-124696https://curecurrent.com/trials/training-induced-cerebral-reorganization-in-schizophrenia-124697https://curecurrent.com/trials/shared-decision-making-for-schizophrenia-124698https://curecurrent.com/trials/evaluate-the-pharmacokinetics-of-quetiapine-fumarate-in-chinese-schizophrenic-patients-124699https://curecurrent.com/trials/effect-of-daily-short-message-system-sms-reminders-on-medication-adherence-to-oral-antipsychotics-in-patients-with-schiz-124700https://curecurrent.com/trials/the-effects-of-aripiprazole-on-patients-with-metabolic-syndrome-124701https://curecurrent.com/trials/multiple-dose-safety-study-of-pf-04802540-in-subjects-with-schizophrenia-124702https://curecurrent.com/trials/a-non-interventional-study-evaluating-the-clinical-benefit-and-effectiveness-of-quetiapine-fumarate-extended-124703https://curecurrent.com/trials/trial-for-antidepressant-treatment-for-negative-symptom-of-schizophrenia-with-nrg1-risk-genotype-124704https://curecurrent.com/trials/is-ms14-helpful-in-schizophrenia-124705https://curecurrent.com/trials/a-neurobiological-study-on-heterogeneity-of-schizophrenia-genetic-variations-and-neurobiological-differentiations-124706https://curecurrent.com/trials/assertive-community-treatment-act-in-schizophrenia-spectrum-disorders-124707https://curecurrent.com/trials/transcranial-magnetic-stimulation-tms-in-schizophrenia-124708https://curecurrent.com/trials/efficacy-study-of-early-onset-of-antipsychotic-drug-action-in-schizophrenia-124709https://curecurrent.com/trials/adjuvant-therapy-with-pergolide-in-treating-cognitive-deficits-in-schizophrenia-124710https://curecurrent.com/trials/non-interventional-study-observe-treatment-efficacy-in-maintaining-symptoms-control-in-schizophrenia-with-seroquel-xr-124711https://curecurrent.com/trials/epidemiology-of-schizophrenia-in-bulgaria-124712https://curecurrent.com/trials/standard-comprehensive-intervention-to-treat-first-episode-schizophrenia-124713https://curecurrent.com/trials/a-german-multicenter-study-on-toxoplasma-gondii-in-first-episode-schizophrenia-124714https://curecurrent.com/trials/family-based-genetic-long-term-study-of-brain-function-in-schizophrenia-124715https://curecurrent.com/trials/the-treatment-of-2-chinese-medicines-in-clozapine-induced-hypersalivation-in-schizophrenia-124716https://curecurrent.com/trials/competence-ability-study-in-people-with-schizophrenia-124717https://curecurrent.com/trials/dual-diagnosis-psychosis-and-cannabismisuse-comparison-of-specialized-treatment-versus-unspecified-treatment-124718https://curecurrent.com/trials/heart-rate-changes-in-schizophrenic-and-bipolar-patients-under-the-medication-of-aripiprazole-and-quetiapine-124719https://curecurrent.com/trials/cognitive-remediation-for-schizophrenia-124720https://curecurrent.com/trials/double-blind-placebo-controlled-study-of-raloxifene-for-negative-symptoms-of-schizophrenia-in-postmenopausal-women-124721https://curecurrent.com/trials/acute-psychosis-treatment-in-the-long-term-unitary-group-study-aplus-124722https://curecurrent.com/trials/switching-to-abilify-trial-swat-124723https://curecurrent.com/trials/antidepressant-and-antipsychotic-to-treat-attenuated-positive-and-negative-symptoms-124724https://curecurrent.com/trials/health-evaluation-of-abilify-long-term-therapy-124725https://curecurrent.com/trials/social-skills-training-in-refractory-schizophrenia-124726https://curecurrent.com/trials/study-of-the-effects-of-glycine-on-symptoms-and-memory-in-patients-with-schizophrenia-124727https://curecurrent.com/trials/a-comparison-of-two-cognitive-batteries-in-people-with-schizophrenia-124728https://curecurrent.com/trials/valnoctamide-in-mania-124729https://curecurrent.com/trials/treatment-of-acute-schizophrenia-with-vitamin-therapy-124730https://curecurrent.com/trials/identifying-predictors-of-response-to-antipsychotics-using-a-treatment-algorithm-124731https://curecurrent.com/trials/huperzine-a-to-help-with-mental-problems-and-the-inability-to-care-for-onself-in-patients-with-schizophrenia-124732https://curecurrent.com/trials/antipsychotic-polypharmacy-prevalence-background-and-consequences-124733https://curecurrent.com/trials/large-simple-trial-lst-of-cardiovascular-safety-of-ziprasidone-and-olanzapine-zodiac-124734https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-risperidone-versus-risperidone-plus-low-dose-of-haloperidol-in-the-treatment-of-124735https://curecurrent.com/trials/an-exploratory-open-label-study-of-adjunctive-l-lysine-treatment-in-patients-with-schizophrenia-124736https://curecurrent.com/trials/acceptance-and-commitment-therapy-for-delusions-124737https://curecurrent.com/trials/assessment-of-safety-and-efficacy-of-therapy-for-the-prevention-of-weight-gain-associated-with-olanzapine-124738https://curecurrent.com/trials/quetiapine-extended-release-xr-for-the-management-of-psychotic-aggression-or-agitation-in-adult-acute-psychiatry-124739https://curecurrent.com/trials/aripiprazole-treatment-of-the-prodrome-124740https://curecurrent.com/trials/medication-adherence-in-older-adults-with-serious-mental-illness-124741https://curecurrent.com/trials/linear-and-non-linear-analysis-of-eeg-changes-in-schizophrenia-after-atypical-antipsychotics-medication-124742https://curecurrent.com/trials/changes-in-auditory-verbal-hallucination-during-atypical-antipsychotic-treatment-of-patients-with-schizophrenia-124743https://curecurrent.com/trials/study-of-mental-care-in-spain-124744https://curecurrent.com/trials/study-evaluating-htc-867-in-healthy-young-and-elderly-subjects-124745https://curecurrent.com/trials/a-study-comparing-rapid-acting-intramuscular-olanzapine-and-placebo-in-agitated-patients-with-schizophrenia-124746https://curecurrent.com/trials/safety-and-efficacy-of-study-drug-versus-placebo-for-negative-symptoms-of-schizophrenia-124747https://curecurrent.com/trials/supported-employment-in-a-swedish-context-124748https://curecurrent.com/trials/a-placebo-controlled-trial-of-modafinil-provigil-added-to-clozapine-in-patients-with-schizophrenia-124749https://curecurrent.com/trials/disturbances-of-kynurenine-pathway-of-trytophan-metabolism-in-schizophrenia-a-quantitative-reverse-transcription-polymer-124750https://curecurrent.com/trials/changes-in-hyperprolactinemia-secondary-to-antipsychotics-after-switching-to-quetiapine-124751https://curecurrent.com/trials/safety-pk-and-pd-study-in-healthy-male-japanese-subjects-124752https://curecurrent.com/trials/the-effects-of-varenicline-on-cognitive-function-in-patients-with-schizophrenia-124753https://curecurrent.com/trials/the-new-strategy-for-pharmacological-treatment-in-people-with-schizophrenia-124754https://curecurrent.com/trials/study-evaluating-multiple-ascending-dose-in-schizophrenia-patients-124755https://curecurrent.com/trials/an-observational-study-of-olanzapine-coated-and-orodispersible-tablets-effectiveness-in-schizophrenic-and-bipolar-outpat-124756https://curecurrent.com/trials/efficacy-and-safety-of-risperidone-oral-solution-combination-clonazepam-versus-haloperidol-intramuscular-im-injection-fo-124757https://curecurrent.com/trials/creatine-treatment-in-psychiatric-disorders-124758https://curecurrent.com/trials/lamictal-tm-haloperidol-decanoate-in-schizophrenia-124759https://curecurrent.com/trials/safety-and-tolerability-of-bl-1020-in-hospitalized-subjects-with-chronic-schizophrenia-or-schizo-affective-disorder-124760https://curecurrent.com/trials/the-study-of-atypical-antipsychotics-induced-metabolic-disturbances-124761https://curecurrent.com/trials/a-repeat-dose-study-with-gsk1018921-to-assess-safety-tolerability-pharmacokinetics-pharmacodynamics-in-healthy-volunteer-124762https://curecurrent.com/trials/identification-and-treatment-of-the-liability-to-develop-schizophrenia-124763https://curecurrent.com/trials/seroquel-quetiapine-fumarate-inpractice-evaluation-programme-124764https://curecurrent.com/trials/role-of-minocycline-in-first-episode-psychosis-124765https://curecurrent.com/trials/association-of-multiple-genetic-polymorphisms-with-clozapine-associated-metabolic-change-in-schizophrenia-124766https://curecurrent.com/trials/prevalence-of-the-metabolic-syndrome-in-spr-taking-antipsychotics-124767https://curecurrent.com/trials/recovery-guide-intervention-for-recurrent-psychiatric-hospitalization-124768https://curecurrent.com/trials/effect-on-metabolic-parameters-of-abilify-in-spr-124769https://curecurrent.com/trials/safety-and-efficacy-of-seroquel-in-first-episode-schizophrenia-124770https://curecurrent.com/trials/rapid-dose-escalation-of-quetiapine-versus-conventional-escalation-in-acute-schizophrenic-patients-124771https://curecurrent.com/trials/effect-of-quetiapine-on-negative-symptoms-and-cognition-124772https://curecurrent.com/trials/comparing-the-effect-of-under-the-tongue-olanzapine-versus-swallowed-olanzapine-on-body-mass-index-a-ratio-of-weight-to-124773https://curecurrent.com/trials/antipsychotic-polypharmacy-in-schizophrenia-124774https://curecurrent.com/trials/galantamine-for-cognition-in-people-with-schizophrenia-124775https://curecurrent.com/trials/nicotine-replacement-therapy-for-smoking-cessation-in-schizophrenia-124776https://curecurrent.com/trials/in-patient-study-in-schizophrenic-patients-124777https://curecurrent.com/trials/the-effects-of-nicotine-withdrawal-on-reward-responsivity-in-schizophrenia-124778https://curecurrent.com/trials/complex-problem-solving-training-in-schizophrenic-patients-124779https://curecurrent.com/trials/effect-of-add-on-citalopram-to-risperidone-on-negative-symptoms-in-schizophrenia-124780https://curecurrent.com/trials/quetiapine-related-neurochemical-changes-as-measured-by-magnetic-resonance-spectroscopy-in-schizophrenia-124781https://curecurrent.com/trials/effectiveness-of-anti-psychotic-in-gps-setting-124782https://curecurrent.com/trials/functional-brain-activation-patterns-in-schizophrenia-measured-before-and-after-treatment-124783https://curecurrent.com/trials/pilot-study-to-evaluate-the-efficacy-and-safety-of-quetiapine-fumarate-instant-release-seroquel-ir-in-controlling-agitat-124784https://curecurrent.com/trials/efficacy-safety-of-quetiapine-fumarate-seroquel-placebo-in-the-treatment-of-acutely-ill-patients-with-schizophrenia-124785https://curecurrent.com/trials/study-of-efficacy-and-safety-of-seroquel-quetiapine-fumarate-as-mono-therapy-for-acute-schizophrenic-124786https://curecurrent.com/trials/seroquel-combined-with-cognitive-remediation-therapy-to-conventional-treatment-in-patients-with-schizophrenia-124787https://curecurrent.com/trials/comparison-of-cognitive-functions-of-schizophrenic-patients-treated-with-sertindole-versus-risperidone-124788https://curecurrent.com/trials/seroquel-stack-study-in-schizophrenic-or-schizoaffective-subjects-124789https://curecurrent.com/trials/fast-titration-in-the-treatment-of-schizophrenia-taiwan-124790https://curecurrent.com/trials/neural-inhibition-as-a-mechanism-of-nicotine-dependence-among-persons-with-schizophrenia-124791https://curecurrent.com/trials/efficacy-and-safety-of-celecoxib-as-add-on-therapy-to-risperidone-versus-risperidone-alone-in-patients-with-schizophreni-124792https://curecurrent.com/trials/an-adherence-study-of-antipsychotic-medication-in-outpatients-with-schizophrenia-or-schizoaffective-disorder-124793https://curecurrent.com/trials/a-pharmacogenetic-investigation-of-antipsychotics-in-schizophrenia-and-schizophrenia-like-psychoses-124794https://curecurrent.com/trials/trial-of-ampakine-added-to-clozapine-olanzapine-or-risperidone-in-patients-with-schizophrenia-124795https://curecurrent.com/trials/modafinil-augmentation-therapy-for-excessive-daytime-sleepiness-and-negative-symptoms-in-patients-with-schizophrenia-124796https://curecurrent.com/trials/a-6-week-multicenter-trial-of-varenicline-tartrate-for-cognitive-impairment-in-subjects-with-schizophrenia-124797https://curecurrent.com/trials/risperidone-maintenance-treatment-in-schizophrenia-124798https://curecurrent.com/trials/development-and-pilot-evaluation-of-modified-cognitive-behavioural-therapy-for-adolescents-with-early-onset-psychosis-124799https://curecurrent.com/trials/genetic-expression-in-schizophrenics-treated-with-ssri-augmentation-relationship-to-clinical-and-cognitive-function-124800https://curecurrent.com/trials/randomized-evaluation-of-the-effectiveness-of-clozapine-and-aripiprazole-versus-clozapine-and-haloperidol-in-the-treatme-124801https://curecurrent.com/trials/modafinil-as-an-adjunctive-on-cognitive-functioning-in-patients-with-schizophrenia-124802https://curecurrent.com/trials/cognitive-functioning-related-to-job-tenure-among-patients-with-schizophrenia-124803https://curecurrent.com/trials/the-effect-of-intranasal-administration-of-oxytocin-on-empathic-abilities-124804https://curecurrent.com/trials/to-determine-if-olanzapine-is-more-cost-effective-than-haloperidol-for-the-treatment-of-schizophrenia-124805https://curecurrent.com/trials/recovery-group-pilot-124806https://curecurrent.com/trials/tolerability-and-efficacy-of-high-dose-escitalopram-in-the-treatment-of-patients-suffering-from-schizophrenia-and-obsess-124807https://curecurrent.com/trials/escitalopram-in-schizophrenia-in-ocd-open-label-study-124808https://curecurrent.com/trials/changes-in-heart-rhythms-associated-with-antipsychotic-drug-treatment-124809https://curecurrent.com/trials/donepezil-double-blind-trial-for-ect-memory-disfunction-124810https://curecurrent.com/trials/antipsychotic-response-in-schizophrenia-124811https://curecurrent.com/trials/brief-hospitalization-for-schizophrenia-strategies-to-improve-treatment-outcome-124812https://curecurrent.com/trials/the-effects-of-risperidone-and-olanzapine-on-thinking-124813https://curecurrent.com/trials/5ht3-antagonism-and-auditory-gating-in-schizophrenia-124814https://curecurrent.com/trials/generalization-of-training-in-schizophrenia-124815https://curecurrent.com/trials/quetiapine-vs-haloperidol-decanoate-for-the-long-term-treatment-of-schizophrenia-and-schizoaffective-disorder-124816https://curecurrent.com/trials/shiatsu-adjuvant-therapy-and-placebo-for-schizophrenia-124817https://curecurrent.com/trials/cognitive-behavioral-therapy-124818https://curecurrent.com/trials/social-functioning-in-schizophrenia-124819https://curecurrent.com/trials/qualitative-analysis-on-the-experiences-of-employment-among-schizophrenic-patients-124820https://curecurrent.com/trials/memantine-as-adjunctive-therapy-for-schizophrenia-negative-symptoms-124821https://curecurrent.com/trials/l-theanine-in-the-management-of-schizophrenia-124822https://curecurrent.com/trials/injectable-naltrexone-treatment-of-alcohol-dependence-in-serious-mental-illness-smi-124823https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-mem-3454-as-adjunctive-treatment-in-combination-with-a-preexisting-antipsyc-124824https://curecurrent.com/trials/proof-of-concept-study-of-cognitive-improvement-in-patients-with-schizophrenia-124825https://curecurrent.com/trials/development-of-population-norms-of-the-computerized-neuropsychological-assessment-for-effectiveness-of-the-antipsychotic-124826https://curecurrent.com/trials/glutamatergic-amino-acids-and-oxytocin-levels-in-the-plasma-of-patients-in-first-psychotic-episode-fpe-before-and-after-124827https://curecurrent.com/trials/quality-of-life-qol-in-female-patient-with-schizophrenia-124828https://curecurrent.com/trials/bone-density-in-patients-with-schizophrenia-124829https://curecurrent.com/trials/aripiprazole-augmentation-for-clozapine-treated-patients-with-refractory-schizophrenia-124830https://curecurrent.com/trials/anti-estrogens-a-potential-treatment-for-bipolar-affective-disorder-in-women-124831https://curecurrent.com/trials/seroquel-long-term-nis-for-schizophrenia-patients-124832https://curecurrent.com/trials/a-study-of-adjunctive-treatment-of-cognitive-deficits-in-schizophrenia-124833https://curecurrent.com/trials/energy-homeostasis-under-treatment-with-atypical-antipsychotics-124834https://curecurrent.com/trials/three-year-follow-up-of-a-randomised-controlled-trial-rct-of-an-intervention-for-tobacco-dependence-among-those-with-a-p-124835https://curecurrent.com/trials/dna-diagnostics-for-minimizing-metabolic-side-effects-of-antipsychotics-124836https://curecurrent.com/trials/modulation-of-regional-brain-activation-in-schizophrenic-patients-by-pharmacological-therapy-124837https://curecurrent.com/trials/amisulpride-in-schizophrenic-acute-phase-patients-124838https://curecurrent.com/trials/efficacy-and-tolerability-of-flunarizine-for-the-treatment-of-schizophrenia-comparison-with-haloperidol-124839https://curecurrent.com/trials/minocycline-for-the-treatment-of-early-phase-schizophrenia-124840https://curecurrent.com/trials/efficacy-of-galantamine-to-treat-schizophrenia-124841https://curecurrent.com/trials/a-single-center-double-blind-db-study-of-mem-3454-on-p50-sensory-gating-and-mismatch-negativity-in-schizophrenia-patient-124842https://curecurrent.com/trials/a-randomized-controlled-trial-of-individual-therapy-for-first-episode-psychosis-124843https://curecurrent.com/trials/a-clinical-trial-on-the-antipsychotic-properties-of-cannabidiol-124844https://curecurrent.com/trials/oxcarbazepine-as-an-adjunct-of-antipsychotic-therapy-in-acute-schizophrenia-124845https://curecurrent.com/trials/efficacy-of-selegiline-in-negative-symptoms-of-schizophrenia-124846https://curecurrent.com/trials/study-to-assess-differential-sensitivity-of-2-spatial-working-memory-tests-in-schizophrenics-treated-with-risperidone-124847https://curecurrent.com/trials/treating-psychotic-symptoms-of-young-individuals-presenting-a-first-episode-of-schizophrenia-comparison-of-two-state-of-124848https://curecurrent.com/trials/fazaclo-outcomes-in-the-control-of-schizophrenia-focus-study-survey-124849https://curecurrent.com/trials/treatment-of-neuroleptic-induced-acute-akathisia-with-trazodone-124850https://curecurrent.com/trials/clozapine-augmentation-with-ziprasidone-or-risperidone-a-randomized-prospective-trial-124851https://curecurrent.com/trials/compare-the-effects-of-bifeprunox-and-quetiapine-on-weight-changes-in-stable-schizophrenic-patients-124852https://curecurrent.com/trials/oxygen-therapy-in-schizophrenia-124853https://curecurrent.com/trials/switch-study-of-existing-atypical-antipsychotics-to-bifeprunox-124854https://curecurrent.com/trials/pregnenolone-in-the-management-of-schizophrenia-patients-124855https://curecurrent.com/trials/ect-schizophrenia-serotonin-study-124856https://curecurrent.com/trials/guanfacine-adjunctive-treatment-to-atypical-antipsychotics-for-cognitive-dysfunction-in-schizophrenia-124857https://curecurrent.com/trials/digital-voice-analysis-in-patients-with-schizophrenia-124858https://curecurrent.com/trials/aripiprazole-in-the-treatment-of-acutely-relapsed-patients-with-schizophrenia-124859https://curecurrent.com/trials/dopaminergic-neurotransmission-in-schizophrenia-patients-at-risk-and-healthy-subjects-124860https://curecurrent.com/trials/extract-of-ginkgo-biloba-and-tardive-dyskinesia-124861https://curecurrent.com/trials/amisulpride-in-schizophrenic-patients-124862https://curecurrent.com/trials/soliacs-solian-solution-in-the-acute-setting-124863https://curecurrent.com/trials/effectiveness-of-antipsychotic-combination-with-psychosocial-intervention-on-outcome-of-patients-with-schizophrenia-124864https://curecurrent.com/trials/prevent-first-episode-relapse-prefer-124865https://curecurrent.com/trials/cognitive-determinants-of-psychoeducation-and-information-in-psychoses-124866https://curecurrent.com/trials/bifeprunox-in-the-treatment-of-schizophrenia-124867https://curecurrent.com/trials/injectable-versus-oral-naltrexone-treatment-of-alcohol-dependence-in-serious-mental-illness-smi-124868https://curecurrent.com/trials/evaluation-of-the-antipsychotic-efficacy-of-cannabidiol-in-acute-schizophrenic-psychosis-124869https://curecurrent.com/trials/safety-and-efficacy-study-of-ziprasidone-in-pediatric-psychotic-illness-124870https://curecurrent.com/trials/cell-function-in-schizophrenic-subjects-on-atypical-antipsychotic-drugs-124871https://curecurrent.com/trials/new-drugs-in-the-treatment-of-mood-disorders-124872https://curecurrent.com/trials/treatment-of-childhood-onset-psychiatric-disorders-with-intravenous-immunoglobulin-ivig-124873https://curecurrent.com/trials/imaging-of-brain-receptors-in-healthy-volunteers-and-in-patients-with-schizophrenia-124874https://curecurrent.com/trials/glycine-to-treat-psychotic-disorders-in-children-124875https://curecurrent.com/trials/neuropsychiatric-evaluation-of-healthy-volunteers-and-adults-with-schizophrenia-124876https://curecurrent.com/trials/oral-manifestations-of-aplastic-anemia-124877https://curecurrent.com/trials/i-123-brain-studies-of-serotonin-metabolism-in-psychiatric-patients-and-normal-volunteers-124878https://curecurrent.com/trials/genetic-aspects-of-neurologic-and-psychiatric-disorders-124879https://curecurrent.com/trials/effect-of-transcranial-magnetic-stimulation-on-memory-124880https://curecurrent.com/trials/routine-plasma-level-determination-to-compare-actual-vs-expected-plasma-levels-at-psychiatric-inpatient-admission-124881https://curecurrent.com/trials/supervised-treatment-of-schizophrenia-a-randomized-controlled-trial-124882https://curecurrent.com/trials/genetics-of-schizophrenia-124883https://curecurrent.com/trials/family-study-in-schizophrenia-124884https://curecurrent.com/trials/one-year-drug-treatment-in-first-episode-schizophrenia-124885https://curecurrent.com/trials/maintenance-treatment-vs-stepwise-drug-discontinuation-in-first-episode-schizophrenia-124886https://curecurrent.com/trials/prodrome-based-early-intervention-with-antipsychotics-vs-benzodiazepines-in-first-episode-schizophrenia-124887https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-124888https://curecurrent.com/trials/the-effect-of-a-weight-management-program-during-treatment-with-olanzapine-124889https://curecurrent.com/trials/improving-symptoms-of-schizophrenia-and-schizoaffective-disorder-by-supplementing-medications-with-pravastatin-124890https://curecurrent.com/trials/study-evaluating-rgh-188-in-the-treatment-of-patients-with-schizophrenia-124891https://curecurrent.com/trials/schizophrenia-sensory-gating-deficit-with-quetiapine-124892https://curecurrent.com/trials/self-management-therapy-for-youth-with-schizophrenia-124893https://curecurrent.com/trials/indicated-prevention-with-omega-3-fatty-acids-in-adolescents-with-at-risk-mental-state-for-psychosis-124894https://curecurrent.com/trials/chronic-schizophrenia-with-obsessive-compulsive-symptoms-comorbidity-or-a-subtype-124895https://curecurrent.com/trials/study-comparing-the-affect-of-bifeprunox-vs-olanzapine-on-weight-during-the-treatment-of-outpatients-with-schizophrenia-124896https://curecurrent.com/trials/open-label-extension-study-of-bifeprunox-124897https://curecurrent.com/trials/seroquel-therapy-for-substance-use-disorders-comorbid-with-schizophrenia-124898https://curecurrent.com/trials/galantamine-for-cognitive-deficits-in-schizophrenia-124899https://curecurrent.com/trials/effects-of-atomoxetine-on-cognitive-function-in-schizophrenia-124900https://curecurrent.com/trials/study-evaluating-sca-136-in-subjects-with-acute-exacerbations-of-schizophrenia-124901https://curecurrent.com/trials/study-evaluating-the-safety-and-tolerability-of-sca-136-in-healthy-japanese-male-subjects-124902https://curecurrent.com/trials/study-evaluating-the-safety-and-tolerability-of-sca-136-in-healthy-japanese-and-non-japanese-female-subjects-124903https://curecurrent.com/trials/study-comparing-bioavailability-of-oral-formulations-of-vabicaserin-124904https://curecurrent.com/trials/rapid-versus-conventional-titration-of-quetiapine-in-schizophrenia-schizoaffective-disorder-124905https://curecurrent.com/trials/access-detection-and-psychological-treatments-124906https://curecurrent.com/trials/olanzapine-versus-aripiprazole-in-the-treatment-of-acutely-ill-patients-with-schizophrenia-124907https://curecurrent.com/trials/olanzapine-treated-adolescents-with-schizophrenia-or-bipolar-i-disorder-124908https://curecurrent.com/trials/cognitive-remediation-in-supported-employment-at-human-service-center-hsc-124909https://curecurrent.com/trials/improving-cognitive-function-of-aripiprazole-in-treating-adolescents-and-young-adults-with-psychotic-disorder-124910https://curecurrent.com/trials/a-safety-and-efficacy-study-of-bacopa-monnieri-and-nardostachys-jatamansi-to-treat-schizophrenia-124911https://curecurrent.com/trials/reversal-of-antipsychotic-induced-hyperprolactinemia-weight-gain-hyperglycemia-and-dyslipidemia-124912https://curecurrent.com/trials/analysis-of-genomic-dna-alterations-in-familial-schizophrenia-124913https://curecurrent.com/trials/effect-of-high-dose-b-complex-vitamins-on-the-symptoms-of-schizophrenia-124914https://curecurrent.com/trials/emotional-and-cognitive-abilites-of-schizophrenia-patients-at-various-time-points-124915https://curecurrent.com/trials/study-of-olanzapine-vs-aripiprazole-in-the-treatment-of-schizophrenia-124916https://curecurrent.com/trials/sarcosine-or-d-serine-add-on-treatment-for-chronic-schizophrenia-124917https://curecurrent.com/trials/comparison-of-intramuscular-olanzapine-depot-to-oral-olanzapine-and-low-dose-depot-in-patients-with-schizophrenia-124918https://curecurrent.com/trials/examining-rapid-acting-intra-muscular-olanzapine-in-japanese-patients-with-schizophrenia-124919https://curecurrent.com/trials/weight-gain-management-in-patients-with-schizophrenia-124920https://curecurrent.com/trials/managing-acute-schizophrenia-a-comparison-between-two-atypical-antipsychotics-124921https://curecurrent.com/trials/assessment-of-a-weight-management-program-for-weight-gain-in-patients-with-schizophrenia-124922https://curecurrent.com/trials/comparison-of-intramuscular-olanzapine-and-intramuscular-haloperidol-in-patients-with-schizophrenia-124923https://curecurrent.com/trials/olanzapine-versus-placebo-in-the-treatment-of-adolescents-with-schizophrenia-124924https://curecurrent.com/trials/comparison-of-intramuscular-olanzapine-depot-with-placebo-in-the-treatment-of-patients-with-schizophrenia-124925https://curecurrent.com/trials/a-study-using-rapid-acting-intramuscular-olanzapine-in-agitated-patients-with-schizophrenia-124926https://curecurrent.com/trials/aimhi-nt-relapse-prevention-trial-124927https://curecurrent.com/trials/the-efficacy-of-escitalopram-for-negative-symptoms-in-schizophrenia-124928https://curecurrent.com/trials/the-monitor-of-serum-prolactin-level-in-a-3-months-aripiprazole-trial-124929https://curecurrent.com/trials/the-use-of-selective-estrogen-receptor-modulators-in-the-treatment-of-schizophrenia-a-pilot-study-124930https://curecurrent.com/trials/dutch-prediction-of-psychosis-study-124931https://curecurrent.com/trials/effect-of-switch-to-aripiprazole-on-health-and-smoking-parameters-in-patients-with-schizophrenia-a-pilot-study-124932https://curecurrent.com/trials/the-effectiveness-of-supported-employment-for-people-with-severe-mental-illness-an-rct-in-six-european-countries-124933https://curecurrent.com/trials/rapid-tranquillization-trial-trec-india-ii-124934https://curecurrent.com/trials/antipsychotic-and-motor-effects-of-acp-103-when-administered-in-combination-with-haloperidol-and-risperidone-124935https://curecurrent.com/trials/families-coping-with-mental-illness-program-124936https://curecurrent.com/trials/aripiprazole-for-the-treatment-of-schizophrenia-with-co-morbid-social-anxiety-124937https://curecurrent.com/trials/efficacy-of-high-dose-olanzapine-for-the-treatment-of-schizophrenia-and-schizoaffective-disorder-124938https://curecurrent.com/trials/association-between-schizophrenia-and-cancer-124939https://curecurrent.com/trials/family-perspectives-treatment-of-psychiatric-illnesses-with-atypical-long-acting-injectable-antipsychotic-medication-124940https://curecurrent.com/trials/israel-multicenter-d-serine-study-imser-for-the-treatment-of-schizophrenia-124941https://curecurrent.com/trials/reboxetine-adjuvant-therapy-for-the-treatment-of-schizophrenia-124942https://curecurrent.com/trials/the-national-danish-schizophrenia-project-124943https://curecurrent.com/trials/quetiapine-decreases-smoking-in-patients-with-chronic-schizophrenia-124944https://curecurrent.com/trials/genetics-and-psychopathology-in-the-22q11-deletion-syndrome-124945https://curecurrent.com/trials/haloperidol-vs-risperidone-in-the-treatment-of-aggression-in-psychotic-inmates-124946https://curecurrent.com/trials/glucose-regulation-during-risperidone-and-olanzapine-treatment-124947https://curecurrent.com/trials/niacin-flushing-as-marker-of-cannabis-effects-on-arachidonic-acid-pathways-in-schizophrenia-124948https://curecurrent.com/trials/cognition-functioning-and-quality-of-life-124949https://curecurrent.com/trials/a-comparative-study-of-new-medications-for-psychosis-in-adolescents-124950https://curecurrent.com/trials/brain-cell-injury-in-patients-with-a-first-episode-of-psychosis-124951https://curecurrent.com/trials/depakote-er-plus-an-atypical-antipsychotic-vs-an-atypical-antipsychotic-alone-in-the-treatment-of-schizophrenia-124952https://curecurrent.com/trials/a-first-in-human-study-of-pf-00184562-in-healthy-volunteers-124953https://curecurrent.com/trials/a-combination-of-two-currently-approved-drugs-to-enhance-the-treatment-of-schizophrenia-124954https://curecurrent.com/trials/olanzapine-versus-an-active-comparator-in-the-treatment-of-schizophrenia-124955https://curecurrent.com/trials/olanzapine-versus-active-comparator-in-the-treatment-of-depression-in-patients-with-schizophrenia-124956https://curecurrent.com/trials/pharmacokinetic-characterization-of-intramuscular-olanzapine-depot-124957https://curecurrent.com/trials/risperidone-and-olanzapine-for-the-schizophrenic-patients-with-neuroleptic-induced-acute-dystonia-or-parkinsonism-124958https://curecurrent.com/trials/sarcosine-n-methylglycine-monotherapy-for-schizophrenia-124959https://curecurrent.com/trials/care-study-improving-treatment-for-the-most-severely-ill-with-schizophrenia-124960https://curecurrent.com/trials/d-serine-monotherapy-for-schizophrenia-124961https://curecurrent.com/trials/risperidone-induced-hyperprolactinemia-treated-with-bromocriptine-124962https://curecurrent.com/trials/risperidone-alone-vs-risperidone-plus-valproate-in-the-treatment-of-patients-with-schizophrenia-and-hostility-124963https://curecurrent.com/trials/trial-of-cognitive-behavioral-therapy-for-schizophrenia-124964https://curecurrent.com/trials/the-impact-of-quetiapine-on-the-drug-abuse-patterns-of-addicted-schizophrenic-patients-124965https://curecurrent.com/trials/psychological-intervention-for-persons-in-the-early-initial-prodromal-state-124966https://curecurrent.com/trials/measurement-of-activity-participation-for-persons-with-schizophrenia-living-in-the-community-124967https://curecurrent.com/trials/the-establishment-of-the-early-intervention-program-for-patients-with-schizophrenia-124968https://curecurrent.com/trials/a-genetic-linkage-study-of-schizophrenia-124969https://curecurrent.com/trials/a-positional-cloning-study-on-schizophrenia-124970https://curecurrent.com/trials/a-study-on-risk-mutations-of-vulnerability-genes-of-schizophrenia-124971https://curecurrent.com/trials/molecular-genetic-study-of-schizophrenia-parent-offspring-trios-124972https://curecurrent.com/trials/a-psychopathological-study-of-latent-early-schizophrenia-clinical-pathology-neuropsychological-dysfunctions-124973https://curecurrent.com/trials/a-study-on-etiological-factors-of-schizophrenia-124974https://curecurrent.com/trials/a-study-on-psychopathological-progress-of-early-schizophrenia-like-disorder-sopres-124975https://curecurrent.com/trials/the-quality-of-life-of-patients-with-severe-illnesses-124976https://curecurrent.com/trials/recovery-therapy-trial-124977https://curecurrent.com/trials/schizophrenia-and-genetic-counseling-124978https://curecurrent.com/trials/assertive-community-treatment-in-copenhagen-124979https://curecurrent.com/trials/do-self-report-and-physician-impressions-of-adherence-to-oral-antipsychotic-medication-agree-with-objective-data-124980https://curecurrent.com/trials/cognitive-remediation-and-social-skills-training-in-schizophrenia-124981https://curecurrent.com/trials/effective-adjunctive-use-of-pergolide-for-cognitive-impairment-and-negative-symptoms-in-schizophrenia-124982https://curecurrent.com/trials/aggressive-acts-among-patients-with-schizophrenia-124983https://curecurrent.com/trials/olanzapine-versus-clozapine-in-treatment-refractory-schizophrenia-124984https://curecurrent.com/trials/mutation-screening-and-translocation-detection-of-disc1-gene-in-schizophrenia-124985https://curecurrent.com/trials/mutation-screening-and-translocation-detection-of-disc1-gene-in-schizophrenia-124986https://curecurrent.com/trials/optimization-of-acute-treatment-in-first-episode-schizophrenia-124987https://curecurrent.com/trials/psychiatric-day-hospital-treatment-124988https://curecurrent.com/trials/psychological-intervention-for-relapse-prevention-in-first-episode-schizophrenia-124989https://curecurrent.com/trials/ethyl-eicosapentaenoic-acid-and-tardive-dyskinesia-124990https://curecurrent.com/trials/akathisia-restless-legs-syndrome-in-people-with-schizophrenia-and-mental-retardation-124991https://curecurrent.com/trials/exploring-predicting-and-intervening-on-long-term-viral-suppression-electronically-124992https://curecurrent.com/trials/dor-isl-in-pediatric-participants-with-hiv-1-18-years-of-age-and-35-kg-124993https://curecurrent.com/trials/ending-the-epidemic-interventions-in-the-dental-setting-uh3-124994https://curecurrent.com/trials/mechanisms-of-cardiac-dysfunction-in-hiv-and-the-effect-of-statins-a-cardiac-mri-study-124995https://curecurrent.com/trials/olfactory-function-and-model-based-behavior-in-people-living-with-hiv-and-sud-124996https://curecurrent.com/trials/strength-training-and-endurance-exercise-for-life-124997https://curecurrent.com/trials/feasibility-of-hpv-testing-with-mail-delivered-sample-collection-kits-124998https://curecurrent.com/trials/a-nurse-case-management-intervention-to-improve-mdr-tb-hiv-co-infection-outcomes-124999https://curecurrent.com/trials/heme-25-open-label-feasibility-study-of-elranatamab-utilized-as-consolidation-in-newly-diagnosed-plasmablastic-lymphoma-125000https://curecurrent.com/trials/prevention-ambassadors-intervention-to-promote-hiv-service-engagement-in-the-networks-of-ssp-clients-125001https://curecurrent.com/trials/ambispective-observational-study-on-retention-in-care-and-on-clinical-chracteristics-of-hiv-infected-women-treated-with-125002https://curecurrent.com/trials/pre-exposure-prophylaxis-study-of-lenacapavir-in-cisgender-men-transgender-women-transgender-men-and-gender-nonbinary-pe-125003https://curecurrent.com/trials/peer-led-dynamic-choice-hiv-prevention-for-women-the-peer-led-dcp-randomized-trial-125004https://curecurrent.com/trials/peer-led-dynamic-choice-hiv-prevention-for-women-the-peer-led-dcp-pilot-study-125005https://curecurrent.com/trials/lifestyle-dietary-patterns-and-cardiometabolic-risk-in-metabolic-dysfunction-associated-steatotic-liver-disease-among-pe-125006